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INTRODUCTION 
 Depression is a chronic mental illness that causes alteration in mood, 
behavior, thoughts and physical health. It’s a common disorder that may even 
affect person’s individual ability to enjoy life and by causing a decline in 
capacity to undertake even the simplest daily tasks. Apart from its chronic 
nature, symptoms associated with depression are often recurring and life 
threatening. Depression is one of the leading causes of disability- adjusted life 
year (DALY) and According to WHO (World Health Organization) 
approximately 350 people worldwide are said to be suﬀer from this disorder.  
Even after remission of depression there is impairment in social functioning1. 
Various factors are responsible for such impairment.  
 As mentioned in the Diagnostic and Statistical Manual of Mental 
Disorders, 5th edition (DSM- V) the main feature of major depressive disorder 
(MDD) is the development of depressed mood (dysphoria) and loss of interest 
in activities that were most pleasurable in the past (anhedonia) which present 
for the duration of two weeks. These symptoms must also be presented by at 
least four of the following features such as changes in the appetite or weight, 
changes in the sleep patterns, altered psychomotor activity, feelings of 
worthlessness or guilt, difficulty in concentration or making decisions and 
thoughts of death or suicidal ideation.  
 Even though there are many drugs developed for the treatment of 
depression, patients even after taking antidepressants fail to attain full 
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remission of disease. Some patients also develop treatment resistant depression 
in which the patients fail to respond to the available drugs or other therapeutic 
approaches. Social and occupational functioning impairment is present in most 
of the cases diagnosed with depression.  
 Hence while treating depressive disorder it is very important to assess 
the level of social and occupational functioning which can be done through 
validated measuring scale called SOFAS (social and occupational functioning 
assessment scales). During treatment and follow up, these measures should be 
consistently measured so that prognosis of the individual will be better. 
 Apart from above things there are certain conditions were much 
importance is not provided in our set up such as Alexithymia and somatization. 
It has been proved in many studies supporting that alexithymia and 
somatization occurs in depressed individuals2. 
 Exploring these factors in our set up has been supported by very limited 
studies hence in this study we tried to explore this hidden factors using 
validated measure and put-forth the results. 
ALEXITHYMIA 
 Alexithymia is defined as a “personality construct characterized by the 
sub-clinical inability to identify and describe emotions in the self”. The core 
characteristics of alexithymia are marked dysfunction in emotional awareness, 
social attachment, and interpersonal relating. Individuals suffering from 
alexithymia also have difficulty in distinguishing and appreciating the emotions 
 
3
of others, which is thought to lead to un-empathic and ineffective emotional 
responding3,4. 
 Alexithymia is prevalent in approximately 10% of the general 
population and is known to be comorbid with a number of psychiatric 
conditions. In studies of the general population the degree of alexithymia was 
found to be influenced by age, gender and various factors. several studies have 
reported that the prevalence rate of alexithymia is less than 10%5. The 
existence and study of Alexithymia experiences started as early in the 1970's. 
Some research suggest that alexithymia is more predominant in men than 
women5,6. 
Alexithymia has two components; 
  A cognitive component where people might face difficulties with 
thinking and emotions while trying to describe, understand and talk about 
feelings. 
An affective component where people might struggle with the experience of 
sharing, responding to and sensing emotions. 
 Alexithymia is present in many of psychiatric conditions like 
depression, anxiety, personality disorder, substance use disorder, 
schizophrenia, panic disorder, eating disorder, etc. and medical conditions like 
systemic hypertension. Cardiovascular disease, inflammatory bowel disease, 
fibromyalgia etc7,8. 
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 Alexithymia can be measured by a self -report scale comprised of 20 
items scale developed by Baghby et al n 1994. Each items rated on a five point 
Likert scale ranging from 1 strongly disagree to 5 strongly agree. TAS-20 is a 
reliable measure of emotion processing in adults which includes a total score 
and three subscales includes 
DIF-difficult in identifying feeling,  
DDF- difficulty in describing feeling, 
EOT-difficulty in externally oriented thinking9. 
 Higher alexithymia scores were significantly associated with more 
severe depression symptoms. The DIF and DDF scales were significantly 
positively related to depression severity, indicating that patients with more 
severe depression reported greater difficulty in identifying and describing their 
feelings. 
SOMATIZATION 
 Soma’ means body. Somatic symptoms are the symptoms experienced 
in the body like physical sensations, experiences or movements. Few examples 
include dizziness, pain, nausea and fainting. Various problems can be felt as 
somatic symptoms but not all symptoms gain attention in daily routine 
activities or causing distress or impairment to the individuals. Somatization is a 
normal human experience, but sometimes these body symptoms cause 
problems in everyday life10,11. 
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 In literature various terms have been used to describe somatic symptoms 
in depression as like somatic, somatized, physical, somatoform, bodily, painful, 
vegetative, psychosomatic, masked, medically unexplained. These terms had 
been used for different diagnostic and theoretical concepts12. 
Common somatic symptoms include 
• abdominal pain 
• headache 
• fatigue 
• nausea 
• chronic pain 
somatic symptoms can be rated using somatic symptoms severity scale-patient 
health questionnaire physical symptoms; 
 Alexithymia and somatization is seen in patients with depression. Even 
after remission of depression there is impact in the impairment of social 
functioning to certain extent.  Studies regarding alexithymia has been done 
since many years but Indian studies on alexithymia is very few. This study 
focus on alexithymia and somatization in patients presenting with depressive 
illness and how it is impacted on their social functioning. In this study we have 
tried to establish the prevalence of alexithymia and somatization in depressive 
individuals and compare various sociodemographic profiles, and illness 
domains pertaining to both alexithymia and somatization. We have also tried to 
 
6
assess how these both contribute to social functioning impairment in depression 
disorder. By doing this study it is easy for a treating person to identify the 
individuals with these two major factors which helps in part of assessing 
prognostic factors and to consider close follow up among these two groups of 
individuals and thereby to reduce the dropout rate and also to attain a good 
recovery from illness.  
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REVIEW OF LITERATURE 
ALEXITHYMIA 
 Alexithymia is defined as a “subclinical phenomenon that involves lack 
of emotional awareness or more specifically there is difficulty in describing 
feelings and identifying feelings and also in distinguishing feelings from the 
bodily sensation of emotional arousal” (Nemiah et al.) 
LEXIXOLOGY 
  The term alexithymia was coined by psychotherapists John Case 
Nemiah & Peter sifneos in the year 1973. Nemiah was the editor of American 
journal of psychiatry. His interest is in the field of psychosomatic researches 
and he worked in Boston Institute of psychoanalysis. Word Alexithymia comes 
from Greek ‘a’- ‘not’; ‘lexis’- ‘words’; thymos, ‘heart’- emotions, which 
literally means“ no words for emotions”. 
DEFINITION- by Graeme J Talor-1997 
1- “Difficulty identifying feelings and distinguishing between feelings 
and the bodily sensation of emotional arousal 
2- Difficulty describing feelings to other people 
3- Constricted emotional process as evidenced by scarcity of fantasies 
4- A stimulus bound externally oriented cognitive styles” 
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 Alexithymia is considered as a personality trait that may places affected 
individuals in a risk for other psychiatric and medical disorders. It is 
dimensionally personality trait that varies in severity from individual to 
individuals.13 
DESCRIPTIONS 
  Deficit in Alexithymia may include identifying problems and 
processing it and also it also deficit in describing and working with one’s own 
feeling. It is often marked by a significant lack of understanding the feelings of 
others. 
 According to Parker, James DA et al. confusion of physical sensations is 
associated with emotions; or fantasies due to restriction of imagination; and 
concrete, realistic and logical thinking often due to the exclusion of emotional 
responses to the problems14. 
 According to Nemiah et al., some Alexithymia individuals may 
contradict the above described characteristics because those individuals may 
experience chronic dysphoric mood or shows outbursts of crying or rage15. 
 Individuals who are suffering from alexithymia think themselves in such 
an operative way and appear to be over adjusted to the setting of reality.  
 In psychotherapy however a disturbance in cognition become very 
apparent as patients tend to recount trivial, chronologically ordered actions, 
reactions, and events of daily life with monotonous details4. 
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 Definition of Alexithymia by -Freyberger; Nemiah; Sifeneos; 1976., 
Alexithymia is a “cognitive affective deficit characterized by  
A) Difficulty in identifying and describing feeling 
B) Difficulty in distinguishing between feelings and bodily sensations 
C) Impaired symbolic activity as evidenced by paucity of fantasy and other 
imaginative activity. 
D) Externally oriented thinking i.e. preferences for focusing on external 
events rather than inner experience.” 
 Alexithymia is associated with a reduced emotional functioning and 
difficulties in understanding and communicating emotion and feeling are its 
core feature. 
 Apart from its affective deficits, it has also been associated with 
numerous other affective difficulties which include symptoms of anhedonia 
(reduced capacity for positive emotional experience, prevalence of and 
proneness towards negative emotions poor emotional regulation and stress 
management abilities16. 
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ALEXITHYMIA – REGULATION 
 
 
Fig-1- regulation of alexithymia 
DIF-difficulty in identifying feeling  
DDF-difficulty in describing feeling   
EOT- externally oriented thinking 
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CLASSIFICATION OF ALEXITHYMIA 
  During dynamic psychotherapy the capacity of the individual to 
symbolize and translate the emotions into language is often considered to be 
one of the critical scenarios for improvement of symptoms. These capacities 
are greatly reduced/ lacking in Alexithymia. 
 Alexithymia is considered to have both state-dependent and trait 
dependent features17. 
 Trait dependent features are associated with traits of personality 
including avoidant, schizotypal, dependent and passive aggressive (Nicol G, et 
al18) and as described by Bach M, de Zwaan M, et al19-lack of association with 
histrionic features reinforce the notion that the construct of Alexithymia 
captures psychological dimensions related to individual differences. 
TYPES OF ALEXITHYMIA  
    1. Primary alexithymia 
    2. Secondary alexithymia 
    3. Organic alexithymia 
Messina A, Beadle JN, Paradiso S. et al.20 
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PRIMARY ALEXITHYMIA 
 Alexithymia is considered to be primary when it emerges as a lifelong 
dispositional factor that can lead an individual to psychosomatic illness. Often 
It derives from a psychic trauma occurring during the period of childhood or 
from the negative primary caregiver interactions (Krystal et al). It has been 
recently suggested that genetic polymorphism of serotonin transporter inked 
with the promotor region i.e. L/L alleles may influence the occurrence of 
alexithymia21,22. 
  Hence the primary alexithymia is currently considered as more or less 
stable personality trait that becomes moulded during the period of childhood 
and early adulthood years therefore primary alexithymia is developmental in 
nature. It also has no purported organic /psychological risk factors. 
SECONDARY ALEXITHYMIA 
According to Wise TN, Mann LS, Mitchell JD et al.23.It is posited to arise not 
during the period of development but resulted as a consequence of events that 
occurring in the later life. It may be linked due to events with psychological 
significance and or medical/ surgical events (illness or disease) that may have 
significant distress or indirect effect on functioning of brain and therefore 
secondary alexithymia may have both psychological and or somatic 
mechanism23. 
 According to the freyberger et al., if the stress full event is in the form 
of an illness, as a process of defense mechanism alexithymia will evoke in an 
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individual which makes an attempt to manage/cope up with the stress of that 
illness24. 
 Study done by wise et al., among 53 inpatients of alexithymia 
individuals examined in a teaching hospital psychiatric consultation services 
and researcher has been arrived to the result that alexithymia acts as a 
defensive role as a process of state reaction in the medically ill individuals. In 
other words, alexithymia which occurs secondary to a psychologically 
significant stressor/event may develop as a protection or defense against highly 
emotional events24,25. 
 This evidence is adequately supported in one of the study done by 
Yehuda.R, steiner et al, and found that alexithymia is found among holocaust 
survivors and in another study done by Zeitlin S.B, Mcnally R J, Cassiday KL, 
suggested that alexithymia is also found in most of sexual assault victims26,27.  
Messina et al, in 2011 found reason that decreased oxygen tension to the brain 
is the causes for secondary alexithymia 
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Precisely defining both above types as  
PRIMARY ALEXITHYMIA - Is a vulnerability factor for mental illness, 
widely considered to be a personality trait in the which affective processing is 
less developed than normal due to childhood trauma or genetic predisposition. 
SECONDARY ALEXITHYMIA- Is a consequences of illness as a condition 
occurring later in life either due to psychological trauma or as a direct insult to 
brain regions which is associated with the emotion processing and awareness.  
Organic Alexithymia- a specific subtype of secondary alexithymia  
     Organic alexithymia refers to a condition in which alexithymia is caused 
by organic damage to brain structures involved in emotional processing 
through indirect/ direct insults to brain28. 
. 
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SOCIODEMOGRAPHIC VARIABLES AND ILLNES PARAMETERS 
IN ALEXITHYMIA RELATED WITH DEPRESSION 
 Study done by Taycan O et al found that alexithymia is found in the 
mean age of 32.41±10.02 among depressed individuals. He measured 
alexithymia using the validated TAS-20(TORONTO AEXITHYMIA SCALE-
20) scale were the individuals scored highfalls under the above mentioned 
mean age. and in another other study done by Mattila AK et al and 
Honkalampi.K.et al found that mean age of (48.1±9.8) are more significant for 
alexithymia32,33,34. 
 Salminen et al. and Honkalampi.K.et al.  studied about the gender 
attribution in alexithymia and other sociodemographic factors related with 
alexithymia and found prevalence of alexithymia is more among men on 
comparing with females33,34. 
 Honkalampi K, Hintikka J et al 34stated that alexithymia is more 
common among divorced and unmarried individuals when compared with 
married individuals. 
 With respect to economic status studies done by Kokkonen P et al35 had 
found that the analyzed indicators of socio-economic status (education, income, 
employment) showed decreasing TAS-20 sum scores with ascending social 
status. 
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On evaluating the role of family and environment studies done by Evren 
C et al and Kooiman CG et al demonstrated that type of parenting and family 
discord has been related as a possible predictor for the development of 
Alexithymia in an individual36,37. 
 Study done by Rybakowski et al. evaluated the relation of family history 
of psychiatric illness in accordance with Alexithymia and found that family h/o 
of disorders like substance use disorders, mood disorders are commonly 
associated with alexithymia38,39. 
 Medical comorbidity in alexithymia has been investigated in earlier 
studies and found that diseases pertaining cardiovascular system, gastro 
intestinal system, central nervous system disease40,41 are more common system 
involved as a comorbidity. 
 On evaluating the relation of suicidal behavior with alexithymia and 
depression Taiminen TJ et al in his study found that the measurement of 
alexithymia does not yield extra information regarding suicide risk 42.  
 Study done by Connelly, Met al43 with respect to evaluating the stressor 
associated with alexithymia and its impact on depression and established a 
strong evidence with stressors are more prevalent in individuals with 
Alexithymia.  
 Study done by Conrad, R., Wegener et al. found many 
psychopathological Symptoms in major depressive disorder are related with 
alexithymia 44. 
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study done by Günther, V. et Al45 On assessing the proportions of 
depression severity using HAM-D, More the severity of depression is 
associated with higher alexithymia scores. 
NEUROANATOMICAL CHANGES IN ALEXITHYMIA. 
1- Borsci et al, 2009 – stated that decreased grey matter volume in anterior 
cingulate cortex 
2- Romei et al, 2008 and Lumely et al 2000- stated that interhemispheric 
transfer impairment in corpus collosum  
3- Borsci et al, 2009- stated decreased grey matter in right temporal lobe 
4- Lee et al ,2011- stated functional impairment in caudate and fronto-
striatal circuit 
5- Lumley et al ,2000- functional impairment in right hemisphere 
 
NEUROBIOLOGY OF ALEXITHYMIA; 
Traumatic dimension of the origin of Alexithymia. 
 According to Heiberg A, Heiberg A46Alexithymia genesis has been 
located in the early and critical developmental stages which is conceptualized 
by some authors naming secondary alexithymia. It has been associated to 
psychological trauma and impact that emerges from physical and psychological 
ill-treatment, and also from negligence experiences and child sexual abuse. 
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Involvement of self-referential processing involves a default network mode 
involves47 
1-prefrontal cortex 
2-anterior cingulate cortex 
3-posterior cingulate cortex 
4-inferior parietal cortex 
5-Bilateral angular gyrus 
6-medial prefrontal cortex   
 In other words, during the early trauma, damage to above network 
resulting in a lack of awareness in the emotion, thus provoking a difficulty in 
emotional expression and verbal identification which are the components and 
core features of alexithymia48,49. 
Role of Mirror neurons and theory of mind in alexithymia 
 Mirror neurons are suggested to be activated in diverse facial 
expressions, social interaction and implicated in deficit conditions such as 
Alexithymia. 
 Morguchi et alfocused on the relation between alexithymia and mirror 
neurons and identified increased degree of alexithymia is associated with 
increased activity of superior and inferior parietal cortex and premotor cortex 
when compared to group with lesser degrees.50,51 
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 Scholl BJ, Leslie AM52 found that in fundamental aspect of Alexithymia 
development related to an encoded ability in genetic modules which are 
triggered by environmental keys such as language. 
BRAIN STRUCTURES- ROLE OF BRAIN HEMISPHERES IN 
ALEXITHYMIA 
 Initially alexithymia was related to the decreased connection between 
both hemispheres of brain that prevents the processing between right and left 
hemisphere 
Right hemisphere- non-verbal affective unconscious information 
left hemisphere – logical analytical verbal thinking  
 Study done by Bermond B, Vorst HC,  Moormann  P et al.53stressed that 
alexithymia is associated with functional commisurotomy. And zeitlin et 
al54verified it using a topognosis test, which indicates a great association 
between alexithymia and deficient bidirectional interhemispheric 
communication. Romei et al55reasserted by providing new findings by the 
appraisal of magnetic transcranial investigation methods. 
 Goerlich-Dobre et al56investigated and proposed different alexithymia 
subtypes which displays variety of volumetric patterns throughout the brain 
structures which are related to the processing of emotion. There is a reduction 
in gray matter in different brain regions when compared with non-Alexithymia 
in this study. 
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 Few investigations have established an association between the 
alexithymia and right hemisphere injuries. Jessimer et al concluded that higher 
level of alexithymia was related with decreased response in right sided 
hemisphere and they have a lesser capacity in recognizing the facial emotional 
expression57,58. 
Positron emission tomography (PET) has shown that in individuals with 
alexithymia, right hemisphere of brain has lower blood flow when compared 
with individuals who do not have alexithymia. 
 Many studies are done in pertaining to the sex differences59,60,61. 
In males- there is an evidence of altered right hemisphere in individuals 
possessing high degree of alexithymia 
In females- it is related to the bi-hemispheric alterations and also left brain 
predomination59. 
ALEXITHYMIA AND AMYGDALA: RELATED TO FACIAL 
EXPRESSION AND EMOTIONAL REACTIVITY. 
 Many study had been linked with Alexithymia to hypo-function of the 
amygdala during facial emotional processing62,63.  And evidence by goerliche-
Dobre et al stating reduced grey matter volume in right amygdala. 
 In a review done on primary neuro image exploration apart from 
described above there is also reduction I the activity of insula and anterior 
cingulate cortex which implies the reduction of activity in emotion when 
individuals with alexithymia face the external stimuli64. Hence it could be 
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hypothesized that these morphological and functional abnormality could trigger 
the traits of individuals with alexithymia. 
ALEXITHYMIA AND ANTERIOR CINGULATE CORTEX 
 Anterior cingulate cortex is a cortical formation which is located around 
the corpus collosum, which is involved in the emotional processing and 
behavior. 
 Series of Study done by Wingbermühle E, Theunissen H, Verhoeven 
WM, Kessels RP, Egger JI65shown a detriment of function associated with 
ACC in individuals with alexithymia. 
 Using PET kano et al.66demonstrated reduced activity in ACC IN group 
of individuals when they are shown visualization of angry face expression. 
 Karlsson et al.67 demonstrated an association between reduced activation 
of anterior cingulate cortex (ACC) under the induction of emotion such as 
positive/ negative and neutral in women which is mediated by the visualizing 
the cinematographic films and also observed a high frequency of somatization 
in people with alexithymia due to the bigger activation of somatosensory and 
motor cortex. 
 Gündel H, López-Sala A, Ceballos-Baumann AO, Deus J, Cardoner N, 
Marten-Mittag B, et al. 68Described by exploring images of magnetic resonance 
and found a positive correlation of size of right ACC  and Alexihymia  
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ALEXITHYMIA- Genetic consideration  
 In the earlier period in late 1970, heiberg is the first to document that the 
possibility that origin of alexithymia could influenced by the hereditary 
factors69 
 Valera and Berenbaum  explored the study with twins and found an 
association between alexithymia scores obtained in TAS-20 , its dimension and 
genetic factors46 . 
 It has been suggested that modulation of neural system that makes 
connecting bridge of cerebral structures that involved in the emotional and 
cognitive processing is by means of dopaminergic neuron on the substantia 
nigral structures70and also it has been studies that presence of relevant 
polymorphism of dopaminergic neural substrate dopamine (Val66Met and 
DRD2/ANKK Tag IA were associated with lowering volume of  ACC, and 
therefore alexithymia related to dopaminergic role is proposed71 . 
 Ham BJ, Lee MS, Lee YM, Kim MK, Choi MJ, Oh KS, et al from his 
study noticed that val[ 108/158] Met polymorphism is the gene that encodes for 
the enzyme called COMT (caecthol-O- methyl transferase)Which  is involved 
in the catabolism of dopamine, is related to alexithymia70. 
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TORONTO ALEXITYMIA SCALE-20 
  Toronto alexithymia scale (TAS-20) (Bagby et al) is a self-report scale 
comprised of 20 items72. Each item is rated on a five point Likert scale ranging 
from 1 strongly disagree to 5 strongly disagree. 
 It has been translated and validated into 18 languages and its efficacy 
has been evaluated with confirmatory factor analysis. 
 TAS-20 is a reliable and valid measures of emotional processing in 
adults which includes a total score and three subscales. 
DIF-      difficulty in identifying feeling 
DDF-     difficulty in describing feeling 
EOT-      difficulty in externally oriented thinking 
Taylor et al 1988, Bagby et al   1994 b 
 First factor in 3 factor model for TAS-20 consist of seven items 
assessing the ability to identify feelings and to distinguish them from the 
somatic sensation that accompany emotional arousal. 
 Factor -2- consist of five items assessing the ability to describe feeling 
to other peoples. 
 Factor-3- consist of eight items assessing externally oriented thinking 
 Empirical derived cut off score-61 is used to identify feeling with high 
or low alexithymia scales.  
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 It has become most widely used instrument for assessing alexithymia n 
both clinical practice as well as in researches. 
 Over the years there has been accumulating evidence related to reliable 
and valid 
 Study done by James and parker Graeme J Taylor, R.Michal Bagby 
found that 20 items scale- TAS has good reliability and factorial validity in 
community population73,74. 
 In this study 1933 adults (880 men and 1053) women was involved. 
Mean age of sample was 35.47 years, mean level of education was 14.75 years. 
From this study, TAS-20 was replicable in men and women results were 
consistent with several studies 
Internal consistency- 0.70 
Mean inter item-correlation- .20-.40 
Coefficient - .62 men; .63 for women 
Scored more in men> women 
SOMATIC SYMPTOMS AND DEPRESSION  
  Somatic symptoms in depression have been described in various terms 
in the literature for different diagnostic and theoretical concepts12,75. 
 Hamilton M et al, states higher frequency of somatic symptoms 
prevailed in depression patients. Akiskal HS found that depression with 
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somatic symptoms are the most common form of depressive illness 
presentation. It is presented in both inpatient and outpatient care.   
Hagnell O Rorsman B et al, studied about depression and somatic symptoms 
in suicide as prospective longitudinal cohort study. In this 3563 persons were 
followed up for 25 years. 14/19 persons were suffering from depression 
predominately having somatic symptoms76. 
Depression research done by Tylee A Gasper et al, reported that 2 of 3 most 
common symptoms reported during depressive episodes was somatic. 
- Tiredness 
- Decreased energy         
- Listless 
- Decreased sleep  
 WHO conducted multi-centered international studies (n=1146) has 
confirmed 2/3 of patients presents depressive mood along with somatic 
symptoms exclusively and nearly half of the patients has unexplained somatic 
symptoms. 
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SOCIODEMOGRAPHIC VARIABLES AND ILLNES PARAMETERS 
IN SOMATZATION RELATED WITH DEPRESSION 
 Study done by Kroenke K, Spitzer RL et al. in evaluating the Mean age 
of somatization and found the mean age of individuals with depression was 
47±5 years. And it is more common in female gender when compared with 
males77 studies done by Katon W, Kirmayer L.J et al. found that married 
individuals score more on somatization on compared with unmarried 
individuals and also the Prevalence of somatization decreases as socio 
economic status increase78,79. 
 On describing the number of episodes of depressive illness it is found 
that higher number of episodes of episodes severe the somatization Katon W, 
Lin E et al.80. 
 Chandler JD et al.81On assessing the proportion of hospitalization high 
level of somatic score is in hospitalized individuals when compared with non-
hospitalized individuals which is due to the medical comorbidity which 
requires therapeutic intervention for the severity of symptoms82,83. 
 Kirmayer L et al.79assessed the suicidality and stress related with 
somatization in individuals with depression and found that the suicidal attempt 
and stress are more prevalent than the individuals without somatization in 
depression. 
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WOMEN AND SOMATIC SYMPTOMS 
             Study done by Kroenkek, spritzer RL (prime-MD 1000 study) from 4 
primary cases sites evaluated with primary care evaluation of mental disorders 
analyzed to determine gene differences in reporting 13 most common physical 
symptoms. Results obtained shows statistically significant 10 out of 13 
symptoms were (somatoform) physically unexplained symptoms and it is found 
more commonly in women >50%.77,84 
 In another study which is conducted by Jackson et al found that women 
are more prone for somatic symptoms compared to men. A higher 
susceptibility of women for psychosocial stressor and somatic illness stressor 
was held reason for high prevalence for female patients. 
 Intermingling of somatization and depressive symptoms has disposition 
in various ways 
 Depressive mood triggers immediate illness and makes individual to 
report somatic symptom to seek medical care systems  
BURDEN OF SOMATIC SYMPTOMS IN DEPRESSION; 
 Flecke de MP Almeida; Herman H et al found that patients who are 
psycho-pharmacologically treated for depression fails to reach full remission. 
Residual symptoms in majority of patients are somatic in nature generally 
worsening painful somatic symptoms more severe and longer the depressive 
episodes persist. 
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 Fishback DA et al – considered chronic pain as the major risk factor in 
depression  
 Vonkorff and simon – found a significant correlation between intensity 
of pain symptoms and worsening of depressive disorder outcome  
 Neurobiological underpinning of somatic symptoms in depression 
 According to Nemeroff B – neurobiology of depression - 
pathophysiology following things paves way85. 
1. Polygenetic nature 
2. Strong heritable disposition 
3. Early developmental experience of maladaptive neurobiological 
stress system  
 For long time dysfunction in serotonergic / (noradrenergic/ 
dopaminergic neurotransmitter have been considered  
On neuroanatomical basis – tracts of serotonergic system which starts in 
midbrain raphe cell bodies which project into the  
1. Frontal cortex 
2. Basal ganglia 
3. Limbic system 
4. Hypothalamus 
 Nor adrenergic system – originating in locuscoeruleus of brainstem 
projecting to other regions similarly as serotonin tracts  
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 According to Stahls, deficiency in the activity of specific pathways of 
serotonin and norepinephrine leads to differential clinical phenomenology in 
depression commonly psychological and somatic symptoms. 
For somatic symptoms especially vegetative domains involves  
1. Changes in the appetite / weight. 
2. Lack of pleasure 
3. Sexual desire 
4. Abnormalities in sleep 
5. Hypothalamic dysfunction 
 Sleep centers were influenced by both serotonin and nor epinephrine 
brain areas which regulates motor dysfunction striatum/cerebellum and also 
spinal pathways transferring body’s sensory input and modulating the physical 
tiredness. 
 Diffuse cortical circuits - influenced by acetyl choline, histamine, 
norepinephrine, dopamine neurotransmission.  
 According to Bair MJ, Robinson RL, Katon W et al- 2003 
 Imbalance in the neurotransmitters like norepinephrine and serotonin 
which normally serves to inhibit sensory input from musculoskeletal systems, 
intestine and other regions in the body may accentuate pain sensitivity86. 
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 Chronic stress evoked by chronic pain leads to loss of negative 
glucocorticoid feedback in HPA axis and downregulation of glucocorticoid 
receptors within brain and body periphery  
 During chronic pain – loss of serotonergic and noradrenergic tone in 
response to glucocorticoid induced monoaminergic depletion may lead to 
descending inhibitory impulse to the spinal cord to effect and enhancement of 
pain sensation 
 Loss of glucocorticoid inhibition of pro-inflammatory cytokines leads to 
proliferation of peripheral inflammatory events contributing to pain 
sensitization. 
Somatic symptoms severity scale-patient health questionnaire physical 
symptoms; 
 DSM-5-LEVEL-2- somatic symptoms adult measure is an adaptation of 
15 item patient health questionnaire physical symptoms PHQ-15 that assesses 
the domain of somatic symptoms. Each items suggest the individual to rate the 
severity of individual somatic symptoms  
 Each item on PHQ -15 is related on 3 points scale0-not bothered  
1-bothered 2-bothered a lot. 
 Total score range from 0-30 Higher score indicating grades severity of 
somatic symptoms 
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Interpretation 
Level of somatic severity   PHQ-15 
Minimal      0-4 
Low      5-9 
Medium     10-14 
High      `15-30 
 Psychosomatic characteristic of PHQ-15 is a brief, self-administered 
questionnaire that will be useful in screening for somatization and in 
monitoring somatic symptom severity in clinical practice and research as 
proved to be valid and reliable scale84. 
SOCIAL AND OCCUPATIONAL FUNCTIONING IN DEPRESSION- 
related with Alexithymia and Somatization. 
 A World Health Organization Study in Primary Care related with 
somatization in cross cultural perspective which includes India, done by Gureje 
O, Simon GE, Ustun TB, Goldberg DP et al. concluded that Somatization is a 
common problem in primary care across cultures and is associated with 
significant health problems and disability87. 
 Similarly, in alexithymia related with depression there is more amount 
of impairment in social functioning which is evidenced by the previous study 
done by Nicolo G et al. and Delibas H et al.1,18  
 On using the SOFAS was assessing the social and occupational 
functioning is highly reliable and valid tool as evidenced by previous studies 
done by Lee JY, Cho MJ, Kwon JS et al.88 
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AIMS AND OBJECTIVES 
1) To investigate the level of social functioning, alexithymia and 
somatization in patients with depression attending the INSTITUTE OF 
MENTAL HEALTH, CHENNAI. 
2) To determine the impact of alexithymia and somatization on social 
functioning in depression individuals. 
3) To compare the various domains related with alexithymia and 
somatization in depression individuals 
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METHODOLOGY 
SETTING 
 The study was conducted in INSITUTE OF MENTAL HEALTH, 
CHENNAI. The necessary prior permission for conduct of the study was 
obtained from Director and Institutional Ethics Committee, Madras Medical 
College, Chennai. 
STUDY POPULATION 
          Individuals attending INSTITUTE OF MENTAL HEALTH who are 
diagnosed as depressive disorder was involved in the study 
SAMPLE SIZE: 
A total of 100 sample size of depression disorder were included in the study. 
SAMPLE SIZE CALCULATION: 
 For this cross –sectional study, sample size calculation was done in 
accordance with the prevalence of alexithymia 46.4% and somatization 44.6% 
in depression with earlier studies 
 Formula used in cross –sectional studies to calculate sample size is 
Sample size=4pq/L2. We arrive at a sample size of 99 in accordance with this 
study and so a sample size of 100 being enrolled in our study. 
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PERIOD OF STUDY: 
 The study was conducted for a duration of 4 months from April 2017-
september 2017 
SAMPLING METHOD: 
             Non probability sampling cross-sectional 
RESEARCH DESIGN 
           After getting approval from the institutional ethical committee, Madras 
Medical College and also approval from the director of Institute of mental 
health (IMH), Patients consulted in IMH those who are fulfilling the criteria for 
depression according to the ICD-10 were chosen up for the study. This is a 
cross sectional study. Sample size of 100 individuals were selected for the 
study based on the inclusion and exclusion criteria. Written informed consent 
and detailed explanation in individual’s mother tongue has been given before 
enrolling them in the study. After this the individual’s depression severity were 
assessed using the HAMD scale, level of social and occupational functioning 
among individuals were assessed using SOFAS (social and occupational 
functioning assessment scale),  and then scales for Alexithymia  and 
somatization like TAS-20(TORONTO ALEXITHYMIC SCALE), PHQ-15-
SOMATIC SYMPTOM SEVERITY SCALE,  were given to  those individuals 
and categorized  as two group Alexithymia and somatization groups based on 
the interpretation of above scales, after this various domains pertaining to 
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Alexithymia and somatization were compared using statistically appropriate 
measures 
STATISTICAL ANALYSIS 
Statistical analysis was performed using SPSS (IBM SPSS Statistics for 
Windows, Version 23.0, Armonk, NY: IBM Corp. Released 2015) is used. 
Significance level is fixed as 5% (α = 0.05).To compare the proportions 
between variables Chi-Square test is applied, if any expected cell frequency is 
less than five then Fisher’s exact test is used.  
INCLUSION CRITERIA: 
1) Patients diagnosed as depressive disorder as per ICD-10 criteria 
2) Age group 18 years – 60 years 
3) Both male and female 
EXCLUSION CRITERIA 
1) Patients with history of mental retardation, seizure disorder, other 
psychiatric conditions like schizophrenia, anxiety disorders. 
2) Individuals who have not given concepts 
3) Patients who couldn’t provide adequate information were excluded from 
the study. 
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ASSESSMENT SCALES USED 
1. Hamilton depression rating scale -HAMD 
2. Toronto Alexithymia scale -TAS-20 
3. Somatic symptom severity scale/ Physical health questionnaire -
PHQ-15 
4. Social and occupational functioning assessment scale –SOFAS 
INSTRUMENTS USED: 
1) SEMI STRUCTURED PROFORMA 
 It was used to collect subject’s socio-demographic details like name age, 
sex, education, occupation, marital status, address, unemployment in terms of 
months, income   and socio economic status according to modified 
Kuppuswamy scale. And details pertaining to the illness has been collected. 
2) ICD-10 
 International classification of disease- ICD-10 was used to diagnose the 
case of individuals with depression. 
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3) HAM-D 
 Max Hamilton first introduced this Hamilton’s rating scale [HAM-D or 
HDRS]189 in 1960. It is accepted widely and used to assess the severity of the 
depression and helps as a follow up guide to assess the treatment response in 
the recovery phase. 
 It has high inter-rater reliability and validity. Many versions of HDRS 
are available. In HAM-D 21 item version only 17 items were given scores and 
others are taken up for clinical information like hypersomnia, increased 
appetite and concentration and indecision. It takes about 20 minutes to 
administer 
Eight items scored from 0 to 4 and other 9 items are scored from 0 to 2. 
[0= not present;4=very severe]. 
SCORING 
MILD  8-13 
MODERATE 14- 18 
SEVERE 19-22 
VERY SEVERE >23 
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4) PHQ-15 
somatic symptoms can be rated using somatic symptoms severity 
scale-patient health questionarrie physical symptoms; The DSM-5 
Level 2—Somatic Symptom—Adult measure is an adaptation of the 
15-item Patient Health Questionnaire Physical Symptoms (PHQ-15) 
that assesses the domain of somatic symptoms. The measure is 
completed by the individuals. Each item asks the individual (or 
informant) to rate the severity of the individual’s somatic symptom 
SCORING AND INTERPRETATION  
Each item on the PHQ-15 is rated on a 3-point scale 
  (0=not bothered at all;  
1=bothered a little;  
2= bothered a lot). 
 The total score can range from 0 to 30, with higher scores indicating 
greater   severity of somatic symptoms. The clinician is asked review the score 
of each item on the measure during the clinical interview and indicate the raw 
score for each item in the section provided for “Clinician Use.” The raw scores 
on the 15 items should be summed to obtain a total raw score and interpreted 
using the Interpretation Table for the PHQ-15 Somatic Symptom Severity scale 
below: 
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Level of somatic severity   PHQ-15 
Minimal      0-4 
Low      5-9 
Medium     10-14 
High       15-30 
If 4 or more items are left unanswered on the PHQ-15 (i.e., more than 
25% of the total items are missing) the total score should not be calculated. As 
such, the individual (or informant) should be encouraged to complete all of the 
items on the measure. If 1 to 3 items are left unanswered, you should prorate 
the raw score by first summing scores of items that were answered to get a 
partial raw score. Next, multiply the partial raw score by the total number of 
items on the measure (i.e., 15). Finally, divide the value by the number of items 
that were actually answered to obtain the prorated total raw score. 
 Prorated Score = (Partial Raw Score x number of items on the PHQ-15) 
Number of items that were actually answered If the result is a fraction, round to 
the nearest whole number. The prorated total raw score should be interpreted 
using the Interpretation Table for the PHQ-15 Somatic Symptom Severity scale 
above. 
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5) TORONTO ALEXITYMIA SCALE-20 
 Toronto alexithymia scale (TAS-20) is a self -report  scale comprised of 
20 items. Each item is rated on a five point Likert scale ranging from  
 A-STRONGLY DISAGREE       
 B- DISAGREE          
 C- NEITHER AGREE/ NOR DISAGREE 
D-AGREE     
 E-STRONGLY AGREE 
 It has been translated and validated into 18 languages and its efficacy 
has been evaluated with confirmatory factor analysis. 
 TAS-20 is a reliable and valid measures of emotional processing in 
adults which includes a total score and three subscales. 
DIF-      difficulty in identifying feeling 
DDF-     difficulty in describing feeling 
EOT-      difficulty in externally oriented thinking 
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5 POINT LIKERT SCALE 
Out of 20 items  
5 ITEMS NEGATIVELY KEYED 
TOTAL SCORE RANGE 20-100 
SCORES 
<51 –    NON ALEXITHYMIA 
52-60-   POSSIBLE ALEXITHYMIA 
>60-     ALEXITHYMIA 
 
6) SOFAS 
The SOFAS is a new scale that differs from the Global Assessment of 
Functioning (GAF) Scale in that it focuses exclusively on the 
individual's level of social and occupational functioning and is not 
directly influenced by the overall severity of the individual's 
psychological symptoms.  
 Also in contrast to the GAF Scale, any impairment in social and 
occupational functioning that is due to general medical conditions is considered 
in making the SOFAS rating. 
 
 
 
 
45
   The SOFAS is usually used to rate functioning for the current period   (i.e., 
the level of functioning at the time of the evaluation).  
 The SOFAS may also be used to rate functioning for other time periods. 
For example, for some purposes it may be useful to evaluate functioning for the 
past year (i.e., the highest level of functioning for at least a few months during 
the past year). 
 INTERPRETATION OF THE SOFAS Is one by measuring the 
severity level by the range of code begins from 0-100, as the scores increases 
functioning is better.Lower the score, more the impairment level. 
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RESULTS 
  
 The study was conducted at the Institute of mental health, Chennai. 
Patients who were selected are both outpatients and inpatients. Initially full 
physical examination was done to assess the physical status of the patient and 
to look for any severe medical co morbidity and other major psychiatric illness   
 A total of 120patients were enrolled, out of which 12 did not satisfy the 
inclusion criteria, 8 did not give their consent. So finally 100 participants were 
included in the study and informed consent was obtained.  
 Study population consisted of 100 participants  
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SOCIODEMOGRAPHIC DETAILS- 
     TABLE-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STUDY POPULATION  Total  100 
GENDER Males 
Females 
42 
58 
AGE  18-29 years 
30-39 years 
40-49 years 
50-59 years-       
14 
37 
29 
20 
RESIDENTS Urban 
Rural  
66 
44 
SOCIO ECONOMIC STATUS 
 
Lower 
Upper lower 
Lower middle       
Upper middle 
14 
68 
13 
05 
MARITAL STATUS Married              
Unmarried     
Divorce                  
57 
36 
07 
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 Study population consists of 100 participants which includes 58 females 
and 42 male participants.  
 Among participant age group, majority 37% belongs to age between 30-
39 years, 29% belongs to 40-49 years. Only 14% were under the age group 18-
29 years. 
 In our study majority (66%) of the participants were from the urban 
location. 
 Regarding socio economic status according to modified kuppusamy 
scale, 68% belongs to upper lower class in this study. 14% belongs to lower 
class, 13% of participants are from lower middle class and 5% from upper 
middle class. 
 57 participants in the study were married, 36 were single and 7 
participants were divorced. 
 
 
 
 
 
 
 
 
 
 
 
 
49
ALEXITHYMIA PARAMETERS 
    TABLE -2 
S.N0 ALEXITHYMIA 
PARAMETERS 
RESULTS N 
1. TOTAL NUMBER OF 
DEPRESSION INDIVIDUALS 
WITH ALEXITHYMIA  
Males                            
Females                        
33 
26 
2. MEAN AGE  In years 35.36 
3. MARITAL STATUS Married 
Unmarried                    
Divorce                         
29 
24 
06 
4. SOCIO ECONOMIC STATUS  Lower 
Upper lower                 
Lower middle               
Upper middle               
06 
40 
08 
05 
5. FAMILY TYPE Nuclear                         
Joint  
32 
27 
6. NO OF EPISODES OF 
DEPRESSION  
1stepisode 
2nd episode 
3 and more 
22 
21 
16 
7. HOSPITALIZATION  Non hospitalized          
Hospitalized                 
26 
33 
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8. FAMILY H/O PSYCHIATRIC 
ILLNESS 
No                               
Yes                               
14 
45 
9. MEDICAL COMORBIDITY  No  
Yes 
17 
42 
10. SUICIDAL ATTEMPTS  Nil                             
1-2 times                       
2 times                          
26 
27 
06 
11. DURATION OF 
OCCUPATIONAL 
IMPAIRMENT  
Nil-   
1-3 months 
4-6 months 
>6 months 
02 
03 
35 
19 
12. DEPRESSION SEVERITY  Mild 
Moderate                      
Sever                          
Very severe                  
11 
18 
26 
04 
13. SOFAS SCORE Serious impairment      
Moderate impairment  
Mild impairment          
31 
27 
01 
00 
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1. GENERAL PARAMETERS IN ALEXITHYMIA 
 Among 100 participants 59 individuals scored positively for alexithymia 
based on TAS-20 scales. Out of which 33 were males and 26 were females 
with mean age group of 35.36 years. 29 participants were married, 24 were 
single and 6 participants were divorced individuals.68% belongs to upper lower 
class economic status.32 individuals were from nuclear family and 27 
individuals from joint family. 
2. ILLNESS PARAMETERS IN ALEXITHYMIA 
A) Number of episodes of depression- Among 59 individuals of 
depression with alexithymia in this study, 22 participants (37.3%) had 
first episode depression, 21 participants (35.6%) had second episode 
depression. Only 16 participants (27.1%) had 3 and more number of 
depressive episodes. 
B) Hospitalization- Among 59 individuals of depression with 
alexithymia in this study, 33 participants (55.9%) required 
hospitalization i.e. admitted in inpatient care and 26 individuals 
(44.1%)did not require hospitalization. 
C) Family h/o psychiatric illness- 45 Participants (76.2%)had family 
history of psychiatric illness and 14 individuals do not have family 
history of psychiatric illness 
D)  Medical comorbidity- 42 individuals had medical comorbid illness 
and 17 participants didn’t have any medical comorbidity 
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E) Suicidal attempts- 33 participants (56%) in our study had one or more 
suicide attempts. 
F) Duration of occupational impairment- majority of individuals (97%) 
had occupational impairment in our study. Out of which, 35 
participants (59.3%)had occupational impairment for duration about 
4-6 months and19 participants (32.2%)had more than 6 months of 
occupational impairment. Only 2 participants had no impairment. 
G) Depression severity- On evaluating the depression severity with 
HAM-D rating scale it was found that very severe depression was 
found in 4 individuals, severe depression was found in 26 participants, 
18 participants had moderate amount of depression, 11individuals had 
mild amount of depression severity. 
H) Sofas score- On assessing the social and occupational impairment 
using SOFAS scale, it was found that 31 participants (52.5%)had 
serious level of impairment and 22 participants (37.2%) had moderate 
level of impairment and 8 individuals had mild level of social had 
occupational impairment   
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SOMATIZATION PARAMETERS  
     TABLE-3 
S.NO 
 
SOMATIZATION 
VARIABLES 
RESULTS  
1 TOTAL NUMBER OF 
DEPRESSION INDIVIDUALS 
WITH HIGH SOMATIZATION 
Males 
Females 
 
16 
27 
 
2 MEAN AGE   In years 47.16
2 MARITAL STATUS Married 
Unmarried 
Divorce     
33 
08 
02 
3 SOCIO ECONOMIC STATUS  Lower                             
Upper lower                   
Lower middle                 
Upper middle                 
08 
30 
04 
01 
4 FAMILY TYPE Nuclear                          
Joint                               
30 
13 
5 NO OF EPISODES OF 
DEPRESSION  
1st episode 
2nd episode 3 and more  
04 
16 
23 
6 HOSPITALIZATION  Non hospitalized 
Hospitalized          
08 
35 
7 FAMILY H/O PSYCHIATRIC No  06 
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ILLNESS Yes 37 
8 MEDICAL COMORBIDITY  No  
Yes 
07 
36 
9 SUICIDAL ATTEMPTS  Nil 
1-2 times 
2 times                         
21 
20 
02 
10 DURATION OF 
OCCUPATIONAL 
IMPAIRMENT  
Nil 
1-3 months 
4-7 months 
>6 months 
00 
00 
34 
09 
11 DEPRESSION SEVERITY  Mild 
Moderate 
Severe 
Very severe                    
08 
25 
10 
05 
12 SOFAS SCORE Serious impairment 
Moderate impairment 
Mild impairment    
15 
28 
00 
  
1. GENERAL PARAMETERS IN SOMATIZATION 
 Among 100 participants 43 individuals scored high somatization score 
on (PHQ-15 somatic symptom severity scale), among which 16 were males and 
27 were females with mean age group of 47.16 years. 33 participants were 
married. Majority 69.7% individuals belong to upper lower class economic 
status. 30 individuals were from nuclear family and 13 individuals from joint 
family  
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2. ILLNESS PARAMETERS IN SOMATIZATION 
A) Number of episodes of depression-  Among 43 individuals of 
depression with high level of somatic symptoms in this study, 23 
participants (53%) had 3 and more number of depressive episodes and 
16 participants (37%) had second episode depression 
B) Hospitalization- Among 43 individuals of depression with high level 
of somatic symptoms in this study, 35 participants (81.3%) required 
hospitalization i.e. admitted in inpatient care. 
C) Family h/o psychiatric illness- 37 Participants (86.1%)had family 
history of psychiatric illness. 
D) Medical comorbidity- 36 individuals had medical comorbidity. 
E) Suicidal attempts- 22 participants (51%) had past history of suicide 
attempts. 
F) Duration of occupational impairment- All participants had 
occupational impairment. 34 participants (791%)had occupational 
impairment for duration about 4-6 months, 9 participants had more than 6 
months of occupational impairment. 
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G) Depression severity- On evaluating the depression severity with HAM-D 
rating scale it is found that severe depression is found in 10 participants, 
25participants had moderate level of depression, 8 individuals had mild 
amount of depression severity. 
H) Sofas score- On assessing the social and occupational impairment using 
SOFAS scale, it is found that 15 participants had serious level of 
impairment and 28 participants (65.1%) had moderate level of social had 
occupational impairment. 
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C) COMPARING PROPORTIONS –OF MARITAL STATUS  
 
                                                  TABLE-6 
 
Marital status 
Alexithymia 
Non-Alexithymia Alexithymia Total 
N % N % N % 
Married 28 49.1 29 50.9 57 100.0
Unmarried 12 33.3 24 66.7 36 100.0
Divorce 1 14.3 6 85.7 7 100.0
Total 41 41.0 59 59.0 100 100.0
 
 
 
 On comparing the marital status among the participants Alexithymia is 
more among divorce individuals and unmarried individuals, but statistically the 
result obtained is non-significant. 
 
 
 
 
 
 
 
 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 4.253 0.123 
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H) COMPARING PROPORTIONS OF FAMILY H/O OF 
PSYCHIATRIC ILLNESS  
 
 
     TABLE-11 
FAMILY H/O 
PSYCHIATRIC 
ILLNESS 
Alexithymia 
Non-Alexithymia Alexithymia Total 
N % N % N % 
No 9 39.1 14 60.9 23 100.0
Yes 32 41.6 45 58.4 77 100.0
Total 41 41.0 59 59.0 100 100.0
 
 
 
 While assessing the proportion of family history it was found that 60.9% 
of individuals without family h/o of psychiatric illness had alexithymia which 
is higher than that of individuals with family h/o psychiatric illness. 
It is Statistically -non significant. 
 
 
 
 
 
 
 
Chi-Square Test Value p-value 
Pearson Chi-Square 0.043 0.835 
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I) COMPARING PROPORTIONS OF MEDICAL 
COMORBIDITY  
               
                      TABLE-12 
      
 
 On assessing the proportions of medical comorbidity in the study it is 
found that 70.8% of individuals who scored high on alexithymia had no 
medical comorbidity whereas 55.3 % had medical comorbidity which is 
Statistically non –significant. 
 
 
 
 
 
 
 
Medical Comorbidity 
Alexithymia 
Non-Alexithymia Alexithymia Total 
N % N % N % 
No 7 29.2 17 70.8 24 100.0
Yes 34 44.7 42 55.3 76 100.0
Total 41 41.0 59 59.0 100 100.0
Chi-Square Test Value p-value 
Pearson Chi-Square 1.828 0.176 
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J) COMPARING PROPORTIONS OF SUICIDAL 
ATTEMPTS WITH ALEXITHYMIA 
 
     TABLE-13 
Suicidal attempt 
Alexithymia 
Non-Alexithymia Alexithymia Total 
N % N % N % 
Nil 22 45.8 26 54.2 48 100.0
1-2 times 16 37.2 27 62.8 43 100.0
>2 times 3 33.3 6 66.7 9 100.0
Total 41 41.0 59 59.0 100 100.0
 
 
 
 On assessing the proportions of suicidal attempts with alexithymia it is 
found that individuals who attempted more than two times have higher 
percentage of alexithymia 66.7% whereas it was 54.2 % among individuals 
with no suicidal attempt but it is statistically non-significant. 
 
 
 
 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 0.930 0.687 
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K) COMPARING PROPORTIONS OF DURATION OF 
OCCUPATIONAL IMPAIRMENT  
 
   TABLE-14 
Duration of 
occupational 
impairment 
Alexithymia 
Non-Alexithymia Alexithymia Total 
N % N % N % 
Nil 0 .0 2 100.0 2 100.0
1-3 months 1 25.0 3 75.0 4 100.0
4-6 months 29 45.3 35 54.7 64 100.0
>6 months 11 36.7 19 63.3 30 100.0
Total 41 41.0 59 59.0 100 100.0
Chi-Square Test Value p-value 
Fisher's Exact Test 2.098 0.598 
 
 On assessing the proportions of duration of occupational impairment 
with alexithymia in the study it is found that 75% of alexithymia individuals 
have duration of occupational impairment for about 1-3 months, 54.7% had 
impairment for bout 4-6 months and 63.3 % of alexithymia individuals have 
impairment duration of more than 6 months. But results obtained is Statistically 
non -significant 
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B) COMPARING PROPORTIONS –OF GENDER  
    
TABLE-18 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 4.146 0.390 
 
 In our study, even though it is statistically not significant high level of 
somatization is found in female gender i.e. 46.6% whereas among male’s high 
level of somatization is found only in 39% 
 
 
 
 
 
 
 
 
 
Gender 
Somatization level 
Low Medium High Total 
N % N % N % N % 
Male 22 51.2 4 9.8 16 39.0 42 100.0 
Female 21 36.2 10 17.2 27 46.6 58 100.0 
Total 43 43.0 14 14.0 43 43.0 100 100.0 
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C) COMPARING PROPORTIONS –OF MARITAL STATUS 
     TABLE-19 
 
Marital status 
Somatization level 
Low Medium High Total 
N % N % N % N % 
Married 16 28.1 8 14.0 33 57.9 57 100.0
Unmarried 24 66.7 4 11.1 8 22.2 36 100.0
Divorce 3 42.9 2 28.6 2 28.6 7 100.0
Total 43 43.0 14 14.0 43 43.0 100 100.0
Chi-Square Test Value p-value 
Fisher's Exact Test 15.857 0.002 
 
On comparing marital status High level of somatization is seen in individuals 
who are married 57% which is statistically significant p< 0.002 
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D) COMPARING PROPORTIONS –OF SOCIO ECONOMIC 
STATUS 
    TABLE-20 
SES 
Somatization level 
Low Medium High Total 
N % N % N % N % 
Lower 4 28.6 2 14.3 8 57.1 14 100.0
Upper lower 30 44.1 8 11.8 30 44.1 68 100.0
Lower middle 5 38.5 4 30.8 4 30.8 13 100.0
Upper middle 4 80.0 0 .0 1 20.0 5 100.0
Total 43 43.0 14 14.0 43 43.0 100 100.0
 
Chi-Square Test Value p-value 
Fisher's Exact Test 6.506 0.335 
 
 On assessing the socio economic status according to modified 
Kuppusamy scale somatization is more common in lower class of socio 
economic status i.e. 57.1% whereas upper middle class family contributes 20%. 
Prevalence of somatization decreases as socio economic status increases. But 
the Statistically the arrived result is non- significant. 
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E) COMPARING PROPORTIONS –OF FAMILY TYPE  
    TABLE-21 
Family type 
Somatization level 
Low Medium High Total 
N % N % N % N % 
Nuclear 22 35.5 10 16.1 30 48.4 62 100.0
Joint 21 55.3 4 10.5 13 34.2 38 100.0
Total 43 43.0 14 14.0 43 43.0 100 100.0
 
 
 
 On evaluating the type of family, 48.4 % of individual with nuclear 
family scored more on high somatization score whereas individuals with joint 
family contributes 34.2%  But it is statistically not significant 
 
 
 
 
 
Chi-Square Test Value p-value 
Pearson Chi-Square 3.773 0.152 
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H) COMPARING PROPORTIONS OF FAMILY H/O OF 
PSYCHIATRIC ILLNESS  
       TABLE-24 
FAMILY 
HISTORY 
Somatization level 
Low Medium High Total 
N % N % N % N % 
No 12 52.2 5 21.7 6 26.1 23 100.0
Yes 31 40.3 9 11.7 37 48.1 77 100.0
Total 43 43.0 14 14.0 43 43.0 100 100.0
 
 
 
  
 While assessing the proportion of family history of psychiatric illness it 
is found that 48.1% of individuals with family h/o of psychiatric illness had 
high somatization score whereas it is found in 26.1% without family h/o 
psychiatric illness. Statistically not significant 
 
 
 
 
 
 
 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 4.008 0.143 
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I) COMPARING PROPORTIONS OF MEDICAL 
COMORBIDITY  
     TABLE-25 
Medical 
Comorbidity 
Somatization level 
Low Medium High Total 
N % N % N % N % 
No 12 50.0 5 20.8 7 29.2 24 100.0
Yes 31 40.8 9 11.8 36 47.4 76 100.0
Total 43 43.0 14 14.0 43 43.0 100 100.0
 
 
 
 On assessing the proportions of medical comorbidity in the study it is 
found that 47.4% of individuals with medical comorbidity were having higher 
level of somatization whereas 40.8% have medical comorbidity with lower 
level of somatization.which is Statistically non -significant p 0.176. Medical 
comorbidity is seen more in individuals with high level of somatic score 
 
 
 
 
 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 2.951 0.254 
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      DISCUSSION 
 Alexithymia and somatization is most commonly associated with 
depression. Even after remission of depression there is certain extent of 
impairment in the social and occupational functioning in which various factors 
plays a role. In this study we evaluated 100 participants of depressive illness 
and tried to estimate the prevalence of alexithymia and somatization in 
depression individuals using validated tools and tried to explore the impact of 
alexithymia and somatization in those individuals with depressive disorder 
pertaining to the social and occupational functioning. And also to compare the 
various domains related with alexithymia and somatization among depressive 
individuals. 
 In our study out of 100 individuals 58 females and 42 males are enrolled 
based on inclusion and exclusion criteria.  
SOCIO DEMOGRAPHIC CHARACTERSTICS AND ILLNESS 
PAAMETERS IN DEPRESSION RELATED WITH-ALEXITHYMIA 
 Mean age of alexithymia is found in the mean age of 35.36 years. In 
earlier studies done by Taycan Oet al found that alexithymia is found in the 
mean age of 32.41±10.02 among depressed individuals32 
 On investigating the gender proportion our study shows that male 
gender (78%) scored more on the TAS-20, when compared with female 
(44.8%)and it is statistically significant p0.001. which is similar to the earlier 
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study on by Salminen, et al. and Honkalampi.K.et al whohad showed that 
prevalence of alexithymia is more among men on comparing with females33,34 
On evaluating the marital status, a study done byHonkalampi K, 
Hintikka J et al 34 found that alexithymia is more common among divorced and 
unmarried individuals which is also replicated in our study. High TAS-20 
scores were seen more among unmarried individuals 66.5% and divorced 
individuals 85.7% but the result obtained is not statistically significant in our 
study. 
With respect to economic status earlier studies done by Kokkonen P et 
al. found that The analyzed indicators of socio-economic status (education, 
income,employment) showed decreasing TAS-20 sum scores with ascending 
social status35. But our study arrived the result of increasing TAS-20 scores as 
the economic status increases which is due to the reason that in our study 
majority of the individuals enrolled were belong to the upper lower and lower 
class status. 
On evaluating the type of family earlier studies demonstrated that type 
of parenting and family discord has been related as a possible predictor for the 
development of Alexithymia36,37in our study we tried to evaluate the type of 
family set up as a part of socio demographic evaluation and the result which is 
obtained is alexithymia is seen more in the joint family (71.1%) compared with 
nuclear family (51.6%) and the result is statistically significant. 
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On assessing the number of episodes of depressive illness it is found that 
first episode of illness contributes 88% of Alexithymia individuals second 
episode 61.8%, 3rd and more episode constitutes 39.0 % Statistically significant 
p < 0.001 
Study done by Rybakowski et al. found that family history of 
psychiatric illness like substance use disorders, mood disorders are common in 
alexithymia38,39.  In our study on assessing the proportion of family history it is 
found that 60.9% of individuals with high TAS scores is having no family h/o 
of psychiatric illness whereas and 58.4% of individuals had family h/o of 
psychiatric illness and the result obtained is not statistically significant. 
Medical comorbidity in alexithymia has been investigated in earlier 
studies and found that diseases pertaining cardiovascular system, gastro 
intestinal system, central nervous system diseases40,41are more common system 
involved as a comorbidity. In our study On assessing the proportions of 
medical comorbidity in the study it is found that 70.8% of individuals with no 
medical comorbidity were having high TAS scores whereas 55.3% of 
individuals have medical comorbidity which is Statistically non -significant  
p 0.176. 
Taiminen TJ et al in his study found that the measurement of 
alexithymia does not yield extra information regarding suicide risk42In our 
study the proportions of suicidal attempts with alexithymia it is found that 
individuals who attempted more than two times have higher TAS-20 scores 
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66.7% whereas it is 54.2 % among individuals with no suicidal attempt but it is 
statistically non-significant p 0.68 
On assessing the proportions of depression severity using HAM-D, 
More the severity of depression higher the alexithymia scores which is 
statistically significant p 0.005 which is replication of earlier study done by 
Günther,V. et al45. 
SOCIO DEMOGRAPHIC CHARACTERSTICS AND ILLNESS 
PARAMETERS IN DEPRESSION RELATED WITH-SOMATIZATION 
Mean age of somatization is found in the mean age of 47.16 years which 
is in accordance with previous study77. 
Study done by Kroenke K et al77found that in depression somatization is 
most prevalence in female gender. In our study, even though it is statistically 
not significant P 0.390 high level of somatization is found in female gender i.e. 
46.6% whereas males contribute 39.0%. 
On comparing marital status High level of somatization is seen in 
individuals who are married 57% which is statistically significant p< 0.002 
which is accordance with earlier studies done by Katon W, Kirmayer L.J et 
al.78,79. 
On comparing the socio economic status according to modified 
Kuppusamy scale somatization is more common in lower class of socio 
economic status i.e. 57.1% whereas upper middle class family contributes 20%. 
Prevalence of somatization decreases as socio economic status increases. But    
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Statistically the arrived result is non- significant p 0.335.which is in accordance 
with previous study done by kirmayer L et al.79.On evaluating the type of 
family, somatization a is found more in nuclear family which contributes 
48.4% whereas it is 34.2% in joint family Butthe result obtained is statistically 
not significant p 0.152 
On describing the number of episodes of depressive illness it is found 
that higher number of episode inindividuals contributes 56.1% of somatization 
whereas first episode contributes 16.0%in our study. Hence higher level of 
somatization is seen more in subsequent episodes Statistically significant p < 
0.001 which is supported by previous study which reflects the same 
results.Katon W, Lin E et al. 80 
On assessing the proportion of hospitalization high level of somatic 
score is in hospitalized individuals 52.2% whereas non hospitalized individual 
contributes 24.2 %.  Which is statistically significant p 0.02 which is due to the 
possible medical comorbidity which requires therapeutic intervention as 
evidenced by previous studies done by Chandler JD et al.81 
On evaluating the proportions of medical comorbidity in our study it is 
found that 47.4% of individuals with medical comorbidity were having higher 
level of somatization whereas 40.8% have medical comorbidity with lower 
level of somatization.But the result is Statistically non -significant p 0.176. 
Medical comorbidity is seen more in individuals with high level of somatic 
score. Earlier studies established a significant results with medical 
comorbidity82,83. 
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On assessing the proportions of suicidal attempts with somatization it is 
found that individuals of about 46.5% who attempted (1-2) times have higher 
level of somatization score which is statistically significant p 0.052 . 
On evaluating the proportions of depression severity using HAM-D, 
individuals with moderate level of depression had higher somatization score 
64.1% which is statistically significant p 0.012. 
In our study we evaluated the social and occupational functioning using 
SOFAS among the participants and association of Alexithymia and 
somatization were individually interpreted and the results obtained is More the 
severity level of impairment in SOFAS higher the alexithymia scores.  serious 
impairment-73.8%; moderate -55.1%; 
 mild -11.1% which is statistically significant p 0.001. 
Similarly, while assessing the social and occupational functioning using 
SOFAS with somatization 57.1 % of high somatization score found to have 
moderate level of social and occupational impairment, serious impairment-
35.7%. which is statistically significant p0.006. 
As we tried to investigate the alexithymia and somatization and their 
impacts on social functioning in depression individuals, both individuals with 
high TAS-20 scores and also individuals with high somatization scores had 
higher level of impairment n the social and occupational functioning when 
evaluated using the SOFAS. many domains replicated same results as of the 
earlier studies and were also statistically significant. 
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CONCLUSION 
This study provides many information which is significant in depression 
individuals. Since long time alexithymia has been neglected in many countries 
due to the limited availability of evidence based concepts and also difficulty in 
identifying this as  a separate entity due to lack of tools for evaluating. This 
study focus on association of hidden concept alexithymia in depression and 
tried to explore the various domains pertaining to it similarly along with the 
somatization evaluation makes a comparable approach for the improvement of 
social and occupational functioning impairment resulting from the depression. 
This study concludes that alexithymia and somatization are equally associated 
with depression in which alexithymia is seen more in male gender, married 
individual, joint family, higher severity of depression, higher number of 
episodes, non-hospitalized individuals and severe level of social and 
occupational functioning impairment. Whereas somatization seen more in 
female gender, married individuals, severe level of depression, frequently 
hospitalized individuals, higher number of episodes, severe level of social and 
occupational impairment. This study provides the importance that while 
treating the individual with depression it is necessary to assess the somatic 
symptoms and alexithymia scores using appropriate scales as used in this study 
and monitor the progression during follow up along with treatment protocol 
can improve the outcome of the disease and also prevent the social functioning 
impairment thereby improving the quality of life.  
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LIMITATIONS 
1. Study population from the same setting, small sample size. Large 
sample size and control group needed for generalization of results 
2. since our study is a cross sectional study, findings need to be replicated 
in longitudinal studies. 
3. Many studies for correlation of the results were used from European 
countries and Scandinavian countries because of the limitation of studies 
related to alexithymia in Indian set up  
4. For assessing the alexithymia in depression we have used TAS-20 scales 
in English language, it would have been better if it is used in translated 
version. But only few language versions available so far in India (hindi, 
kannada) 
5. Clear cut definition of somatization has not been established it is quite 
often this term somatization used for many somatoforms related 
disorders interchangeably for convenience and diagnostic aspects. 
6. Social and occupational functioning impairment due to other 
comorbidities has been not considered which may be a confounding 
factor in this study. 
7. Treatment adherence in previous episodes and current episodes of 
depression are not considered in this study. 
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FUTURE DIRECTIONS 
          Many studies insisted inconsistencies on methodology and results in 
epidemiological studies related with alexithymia, somatization and depression. 
Therefore, there is a need for prospective and systematic studies which has 
consistent study designs and results.  Findings from previous study shown that 
alexithymia is a stable trait, but when an individual is amounted to 
psychological /physical factors. Studies in future can overcome this state of 
dilemma by assessing alexithymia in the same individual repeatedly across 
various standardized time periods. Measurement of confounding factors like 
negative affect should be assessed simultaneously in order to strengthen the 
study.  Future directions should focus on Neuroimaging and genetic related 
research that may provide us new insights and also to understand the interplay 
of somatization and alexithymia in depression individuals. 
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INFORMATION OF PARTICIPANTS 
 
TITLE- “ALEXITHYMIA AND SOMATISATION IN PATIENTS WITH 
DEPRESSION AND THEIR IMPACT ON SOCIAL FUNCTIONING” 
 
Principal Investigator: Dr. SANJAY.B 
Name of Participant: 
Site:    Institute of Mental Health, Chennai   
 
You are invited to take part in this research. The information in this document is 
meant to help you decide whether or not to take part. Please feel free to ask if you have any 
queries or concerns. 
 
What is the purpose of research? 
 
           Impairment in social functioning are common in depression disorder. Alexithymia 
is marked by difficulties in verbally describing affect and in differentiating mental states 
from bodily sensation and alexithymia is highly associated with depression Somatization 
is the experience of bodily symptoms with no or no sufficient physical cause for them 
with presumed psychological causation it is also associated with depression.   hence this 
study is to find out the contribution and impact of alexithymia and somatization to social 
functioning   in   consecutive sample of depression   patients at Institute of Mental Health, 
Chennai.  We have obtained permission from the Institutional Ethics Committee. 
 
The study design 
 
               Patients with depression diagnosed as per ICD 10 classification are considered 
for the study. Informed consent is taken from the patients. Later100 consecutive patients 
attending the out-patient of Institute of Mental Health, Chennai are taken up as study 
subjects. Impact of alexithymia and somatization   on social functioning in depression 
patient is studied 
 
Study Procedures 
 
Data’s from the patient’s samples of depression attending the outpatient at institute of 
mental health are taken and statistically analyzed to get the results of impact of 
alexithymia and somatization on social functioning in depression. They are chosen for the 
study if they are physically stable after taking an informed consent. later 
standardassessment tools i.e. HAMILTON RATING SCALE for depression, TORENTO 
ALEXITHYMIA SCALE for alexithymia, PHQ-15 SOMATIC SYMPTOMS 
SEVERITYRATING SCALE, SOCIAL AND OCCUPATION FUNCTIONING 
ASSESSMENT SCALE for social function assessment.  
 
 
 
Confidentiality of the information obtained from you 
You have the right to confidentiality regarding the privacy of your medical 
information (personal details, results of physical examinations, investigations, and your 
medical history). By signing this document, you will be allowing the research team 
investigators, other study personnel, Institutional Ethics Committee and any person or 
agency required by law like the Drug Controller General of India to view your data, if 
required. The information from this study, if published in scientific journals or presented 
at scientific meetings,  
will not reveal your identity. 
How will your decision to not participate in the study affect you? 
Your decision not to participate in this research study will not affect your medical 
care or your relationship with the investigator or the institution. You will be taken care of 
and you will not lose any benefits to which you are entitled.  
Can you decide to stop participating in the study once you start? 
 The participation in this research is purely voluntary and you have the right to 
withdraw from this study at any time during the course of the study without giving any 
reasons. However, it is advisable that you talk to the research team prior to discontinuing 
form the study. 
 
 
Signature of Investigator                                                 Signature of Participant   
 
 
Signature of the Guardian      
 
 
Date        Date 
 
 
  
INFORMED CONSENT FORM 
(This is only a guideline – Relevant changes to be made as per the study requirements)  
Title of the study:” ALEXITHYMIA AND SOMATISATION IN PATIENTS WITH DEPRESSION 
AND THEIR IMPACT ON SOCIAL FUNCTIONING AT INSTITUTE OF MENTAL HEALTH” 
Name of the Participant: ______________________________________________________.  
Name of the Principal (Co-Investigator): _ Dr. SANJAY.B 
A______________________________________.  
Name of the Institution:       INSTITUTE OF MENTAL HEALTH 
Name and address of the sponsor / agency (ies) (if any):_No_ 
Documentation of the informed consent   
I _____________________________ have read the information in this form (or it has been read to me). I 
was free to ask any questions and they have been answered. I am over 18 years of age and, exercising my 
free power of choice, hereby give my consent to be included as a participant in  
“ALEXITHYMIA AND SOMATISATION IN PATIENTS WITH DEPRESSION AND THEIR IMPACT 
ON SOCIAL FUNCTIONING AT INSTITUTE OF MENTAL HEALTH “ 
 
1. I have read and understood this consent form and the information provided to me.  
2. I have had the consent document explained to me.  
3. I have been explained about the nature of the study.  
4. I have been explained about my rights and responsibilities by the investigator.  
5. I have been informed the investigator of all the treatments I am taking or have taken in the past 
________ months including any native (alternative) treatment.  
6. I have been advised about the risks associated with my participation in this study* 
 
7. I have not participated in any research study within the past _________month(s). * 
8. I have not donated blood within the past _______ months—Add if the study involves extensive 
blood sampling. * 
9. I am aware of the fact that I can opt out of the study at any time without having to give any reason 
and this will not affect my future treatment in this hospital. * 
10. I am also aware that the investigator may terminate my participation in the study at any time, for 
any reason, without my consent. * 
11. I hereby give permission to the investigators to release the information obtained from me as result 
of participation in this study to the sponsors, regulatory authorities, Govt. agencies, and IEC. I 
understand that they are publicly presented.  
12. I have understood that my identity will be kept confidential if my data are publicly presented  
13. I have had my questions answered to my satisfaction.  
14. I have decided to be in the research study.  
 
I am aware that if I have any question during this study, I should contact the investigator. By signing 
this consent form I attest that the information given in this document has been clearly explained to me 
and understood by me, I will be given a copy of this consent document.  
 
 
 
 
For adult participants:  
Name and signature / thumb impression of the participant (or legal representative if participant 
incompetent)  
Name _________________________ Signature_________________ Date________________  
 
Name and Signature of impartial witness (required for illiterate patients):  
 
Name _________________________ Signature_________________ Date________________  
 
Address and contact number of the impartial witness:  
 
 
 
Name and Signature of the investigator or his representative obtaining consent:  
 
Name _________________________ Signature_________________ Date________________  
 
 
 
Name and Signature of the investigator or his representative obtaining consent: 
 
Name _________________________ Signature_________________ Date________________  
 
 
 
 
 
 
 
Hamilton Depression Rating Scale (HDRS)  
 
 
Reference: Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;  
23:56–62 
 
 
Rating Clinician-rated range (or in clinical remission), while a score of 20 or
Administration time 20–30 minutes higher (indicating at least moderate severity) is usuallyrequired for entry into a clinical trial.  
 
Main purpose to assess severity of, and 
change in,depressive symptoms 
 
Population Adults 
 
 
Commentary 
 
The HDRS (also known as the Ham-D) is the most widely 
used clinician-administered depression assessment scale. 
The original version contains 17 items (HDRS17) pertain-
ing to symptoms of depression experienced over the past 
week. Although the scale was designed for completion 
after an unstructured clinical interview, there are now 
semi-structured interview guides available. The HDRS was 
originally developed for hospital inpatients, thus the 
emphasis on melancholic and physical symptoms of 
depression. A later 21-item version (HDRS21) included 4 
items intended to subtype the depression, but which are 
sometimes, incorrectly, used to rate severity. A limitation 
of the HDRS is that atypical symptoms of depression (e.g., 
hypersomnia, hyperphagia) are not assessed (see SIGH-
SAD, page 55). 
 
 
Versions 
 
The scale has been translated into a number of 
languages including French, German, Italian, Thai, and 
Turkish. As well, there is an Interactive Voice Response 
version (IVR), a Seasonal Affective Disorder version 
(SIGH-SAD, see page 55), and a Structured Interview 
Version (HDS-SIV). Numerous versions with varying 
lengths include the HDRS17, HDRS21, HDRS29, 
HDRS8, HDRS6, HDRS24, and HDRS7 (see page 30). 
 
 
Additional references 
 
Hamilton M. Development of a rating scale for 
primary depressive illness. Br J Soc Clin Psychol 
1967; 6(4):278–96. 
 
Williams JB. A structured interview guide for the 
Hamilton Depression Rating Scale. Arch Gen 
Psychiatry 1988; 45(8):742–7. 
 
 
Scoring 
 
Address for correspondence 
 
Method for scoring varies by version. For the HDRS17, a 
score of 0–7 is generally accepted to be within the normal 
 
The HDRS is in the public domain.  
 
 
 
Hamilton Depression Rating Scale (HDRS) 
 
 
PLEASE COMPLETE THE SCALE BASED ON A STRUCTURED INTERVIEW  
Instructions: for each item select the one “cue” which best characterizes the patient. Be sure to record the answers in the 
appropriate spaces (positions 0 through 4).  
 
1 DEPRESSED MOOD (sadness, hopeless, helpless, worthless)  
0 |__| Absent. 
1 |__| These feeling states indicated only on questioning.
2 |__| These feeling states spontaneously reported verbally.
3 |__| Communicates feeling states non-verbally, i.e. through
  facial expression, posture, voice and tendency to weep.
4 |__| Patient reports virtually only these feeling states in
  his/her spontaneous verbal and non-verbal 
  communication. 
 
2 FEELINGS OF GUILT  
0 |__| Absent. 
1 |__| Self-reproach, feels he/she has let people down.
2 |__| Ideas of guilt or rumination over past errors or sinful
  deeds. 
3 |__| Present illness is a punishment. Delusions of guilt.
4 |__| Hears accusatory or denunciatory voices and/or 
  experiences threatening visual hallucinations. 
 
3 SUICIDE 
 0 |__| Absent. 
 1 |__| Feels life is not worth living. 
 2 |__| Wishes he/she were dead or any thoughts of possible
   death to self. 
 3 |__| Ideas or gestures of suicide. 
 4 |__| Attempts at suicide (any serious attempt rate 4). 
4   INSOMNIA: EARLY IN THE NIGHT 
 0 |__| No difficulty falling asleep. 
 1 |__| Complains of occasional difficulty falling asleep, i.e.
   more than 1⁄2  hour. 
 2 |__| Complains of nightly difficulty falling asleep. 
5   INSOMNIA: MIDDLE OF THE NIGHT 
 0 |__| No difficulty. 
 1 |__| Patient complains of being restless and disturbed 
   during the night. 
 2 |__| Waking during the night – any getting out of bed rates
   2 (except for purposes of voiding). 
6   INSOMNIA: EARLY HOURS OF THE MORNING 
 0 |__| No difficulty. 
 1 |__| Waking in early hours of the morning but goes back
   to sleep. 
 2 |__| Unable to fall asleep again if he/she gets out of bed.
7 WORK AND ACTIVITIES 
 0 |__| No difficulty. 
 1 |__| Thoughts and feelings of incapacity, fatigue or 
   weakness related to activities, work or hobbies. 
 2 |__| Loss of interest in activity, hobbies or work – either
   directly reported by the patient or indirect in 
   listlessness, indecision and vacillation (feels he/she has
   to push self to work or activities). 
 3 |__| Decrease in actual time spent in activities or decrease
   in productivity. Rate 3 if the patient does not spend at
   least three hours a day in activities (job or hobbies)
   excluding routine chores. 
 4 |__| Stopped working because of present illness. Rate 4 if
   patient engages in no activities except routine chores,
   or if patient fails to perform routine chores unassisted.
 
8 RETARDATION (slowness of thought and speech, 
impairedability to concentrate, decreased motor activity) 
 
11 ANXIETY SOMATIC (physiological concomitants of 
anxiety) such as: 
gastro-intestinal – dry mouth, wind, indigestion, 
diarrhea, cramps, belching  
cardio-vascular – palpitations, headaches 
respiratory – hyperventilation, sighing 
urinary frequency 
sweating  
0 |__| Absent. 
1 |__| Mild. 
2 |__| Moderate. 
3 |__| Severe. 
4 |__| Incapacitating.
 
12 SOMATIC SYMPTOMS GASTRO-INTESTINAL  
0 |__| None. 
1 |__| Loss of appetite but eating without staff 
  encouragement. Heavy feelings in abdomen.
2 |__| Difficulty eating without staff urging. Requests or
  requires laxatives or medication for bowels or
  medication for gastro-intestinal symptoms. 
 
13 GENERAL SOMATIC SYMPTOMS  
0 |__| None. 
1 |__| Heaviness in limbs, back or head. Backaches,
  headaches, muscle aches. Loss of energy and
  fatigability. 
2 |__| Any clear-cut symptom rates 2. 
 
14 GENITAL SYMPTOMS (symptoms such as loss of 
libido, menstrual disturbances) 
0 |__| Absent.
1 |__| Mild. 
2 |__| Severe.
 
15 HYPOCHONDRIASIS  
0 |__|   Not present.  
1 |__|   Self-absorption (bodily).  
2 |__| Preoccupation with health. 
3 |__| Frequent complaints, requests for help, etc.
4 |__| Hypochondriacal delusions. 
 
16 LOSS OF WEIGHT (RATE EITHER a OR b)  
a) According to the b) According to weekly  
patient: measurements: 
0 |__| Normal speech and thought. 
1 |__| Slight retardation during the interview.
2 |__| Obvious retardation during the interview.
3 |__|   Interview difficult.  
4 |__|   Complete stupor. 
 
9 AGITATION  
0 |__| None. 
1 |__| Fidgetiness. 
2 |__| Playing with hands, hair, etc. 
0 |__| No weight loss. 
 
1 |__| Probable weight loss 
associated with 
present illness. 
2 |__| Definite (according 
to patient) weight 
loss. 
3 |__| Not assessed. 
0 |__| Less than 1 lb weight loss 
in week.  
1 |__| Greater than 1 lb weight 
loss in week. 
 
2 |__| Greater than 2 lb weight 
loss in week. 
 
3 |__| Not assessed. 
3 |__| Moving about, can’t sit still. 
4 |__| Hand wringing, nail biting, hair-pulling, biting of lips.
 
10 ANXIETY PSYCHIC  
0 |__| No difficulty. 
1 |__| Subjective tension and irritability. 
2 |__| Worrying about minor matters. 
3 |__| Apprehensive attitude apparent in face or speech.
4 |__| Fears expressed without questioning. 
17 INSIGHT  
0 |__| Acknowledges being depressed and ill. 
1 |__| Acknowledges illness but attributes cause to bad food,
  climate, overwork, virus, need for rest, etc. 
2 |__| Denies being ill at all. 
Total score: |__|__|  
 
This scale is in the public domain. 
 
 
 
 
 
 
 
 
 
 
TORONTO ALEXITHYMIA SCALE (TAS-20) 
A-STRONGLY DISAGREE         B- DISAGREE          C- NEITHER AGREE/ NOR DISAGREE 
D-AGREE      E-STRONGLY AGREE 
DIFFICULTY IN IDENTIFYING FEELING 
1- Iamoften confused about what emotion I am feeling 
 
 
2- I have 
personal sensation that even doctors don’t understand 
 
 
 
 
3- when I am upse ; I don’t know if  I am sad /frightened / angry 
 
 
 
4- I am often puzzled by sensation in my body 
 
 
 
 
5- I have feeling that I can’t quite identify 
 
 
 
6- I don’t know what is going on inside my mind 
 
 
7- I often don’t know why I am angry 
 
 
 
 
 
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
DIFFICULTY IN COMMUNICATING FEELING 
 
1 – It is difficult for me to find the right word my words to my feeling 
 
 
 
2- I am able to describe my feelings easily (-ve key) 
 
 
3- I find it hard to describe how I feel about people 
 
 
4- People tell me to do describe my feeling more 
 
 
5- It is difficult for me to describe my innermost feeling even to my close friend 
 
 
 
 
DIFFICULTY IN EXTERNALLY ORIENTED THINKING 
1-  I Prefer to analyze problemrather than  describing them (-ve key) 
 
 
 
2- I prefer to just let things happen rather than to understand why they turned out 
that way 
 
 
 
 
 
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
3- Being in touch with emotion is essential (-ve key)  
 
 
 
4- I prefer talking to people about their daily activities rather than  their feeling  
 
 
 
5- I prefer to watch light entertainment shows rather than psychological dramas  
 
 
 
6- I can feel close to someone even in moment of silence (-ve key) 
 
 
 
7- I find examination of my feelings useful in solving personal problems  (-ve 
key) 
 
 
 
8- Looking for hidden meaning in movies/plays distracts from their enjoyment 
 
 
 
 
 
 
 
 
 
 
 
 
 
INDIVIDUAL SCORE 
RESULT  
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
A B        C         D  E 
     
5 POINT LIKERT SCALE 
5 ITEMS NEGATIVELY KEYED 
 
TOTAL SCORE RANGE 20-100 
SCORES 
<51 –    NON ALEXITHYMIA 
52-60-   POSSIBLE ALEXITHYMIA 
>60-     ALEXITHYMIA 
PHQ-15 SOMATIC SYMPTOM SEVERITY 
SCALE 
 
The APA is offering a number of “emerging measures” for further research and clinical 
evaluation. These patient assessment measures were developed to be administered at the 
initial patient interview and to monitor treatment progress. They should be used in research 
and evaluation as potentially useful tools to enhance clinical decision-making and not as the 
sole basis for making a clinical diagnosis. Instructions, scoring information, and 
interpretation guidelines are provided; further background information can be found in DSM-
5. The APA requests that clinicians and researchers provide further data on the instruments’ 
usefulness in characterizing patient status and improving patient care at 
http://www.dsm5.org/Pages/Feedback-Form.aspx.  
 
 
Measure: LEVEL 2—Somatic Symptom—Adult Patient (adapted from the Patient Health 
Questionnaire Physical Symptoms [PHQ-15]) Rights granted: This measure can be 
reproduced without permission by researchers and by clinicians for use with their patients. 
Rights holder: This measure was adapted from the Patient Health Questionnaire Physical 
Symptoms (PHQ-15]), which is in the public domain 
(http://www.phqscreeners.com/instructions/instructions.pdf). The original measure was 
developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, 
with an educational grant from Pfizer Inc. To request permission for any other use beyond 
what is stipulated above, contact: The measure is in the public domain and can be used 
without permission.   
 
 
 
 
 
 
 
 
 
Name: ____________________________     Age: ____  Sex:       Male      Female  
Date: ______________ If the measure is being completed by an informant, what is 
your relationship with the individual receiving care? ________________ 
 
 
 
 
 
SCORING AND INTERPRETATION 
Each item on the PHQ-15 is rated on a 3-point scale (0=not bothered at all; 
1=bothered a little; 2= bothered a lot). The total score can range from 0 to 30, with 
higher scores indicating greater severity of somatic symptoms.  
The clinician is asked review the score of each item on the measure during the clinical 
interview and indicate the raw score for each item in the section provided for 
“Clinician Use.” The raw scores on the 15 items should be summed to obtain a total 
raw score and interpreted using the Interpretation Table for the PHQ-15 Somatic 
Symptom Severity scale below:  
Interpretation Table for the PHQ-15 Somatic Symptom Severity Scale Levels of 
Somatic Symptom Severity PHQ-15 Score Minimal 0-4 Low 5-9 Medium 10-14 High 
15-30 Note: If 4 or more items are left unanswered on the PHQ-15 (i.e., more than 
25% of the total items are missing) the total score should not be calculated.  
As such, the individual (or informant) should be encouraged to complete all of the 
items on the measure. If 1 to 3 items are left unanswered, you should prorate the raw 
score by first summing scores of items that were answered to get a partial raw score. 
Next, multiply the partial raw score by the total number of items on the measure (i.e., 
15). Finally, divide the value by the number of items that were actually answered to 
obtain the prorated total raw score. 
Prorated Score = (Partial Raw Score x number of items on the PHQ-15) 
Number of items that were actually answered If the result is a fraction, round to the 
nearest whole number. The prorated total raw score should be interpreted using the 
Interpretation Table for the PHQ-15 Somatic Symptom Severity scale above.  
 
  
SOCIAL AND OCCUPATIONAL FUNCTIONING ASSESSMENT 
SCALE (SOFAS) 
                   The SOFAS is a new scale that differs from the Global Assessment of 
Functioning (GAF) Scale in that it focuses exclusively on the individual's level of 
social and occupational functioning and is not directly influenced by the overall 
severity of the individual's psychological symptoms. Also in contrast to the GAF 
Scale, any impairment in social and occupational functioning that is due to general 
medical conditions is considered in making the SOFAS rating. The SOFAS is usually 
used to rate functioning for the current period (i.e., the level of functioning at the time 
of the evaluation). The SOFAS may also be used to rate functioning for other time 
periods. For example, for some purposes it may be useful to evaluate functioning for 
the past year (i.e., the highest level of functioning for at least a few months during the 
past year). Consider social and occupational functioning on a continuum from 
excellent functioning to grossly impaired functioning. Include impairments in 
functioning due to physical limitations, as well as those due to mental impairments. 
To be counted, impairment must be a direct consequence of mental and physical 
health problems; the effects of lack of opportunity and other environmental limitations 
are not to be considered.  
NOTE: 
  The rating of overall psychological functioning on a scale of 0–100 was 
operationalized by Luborsky in the Health-Sickness Rating Scale. (Luborsky L: 
"Clinicians' Judgments of Mental Health." Archives of General Psychiatry 7:407–417, 
1962). 
 Spitzer and colleagues developed a revision of the Health-Sickness Rating Scale 
called the Global Assessment Scale (GAS) (Endicott J, Spitzer RL, Fleiss JL, et al.: 
"The Global Assessment Scale: A Procedure for Measuring Overall Severity of 
Psychiatric Disturbance." Archives of General Psychiatry 33:766–771, 1976). 
 
 The SOFAS is derived from the GAS and its development is described in Goldman 
HH, Skodol AE, Lave TR: "Revising Axis V for DSM-IV: A Review of Measures of 
Social Functioning." American Journal of Psychiatry 149:1148–1156, 1992.  
Copyright © 2008 American Psychiatric Publishing, Inc. All Rights Reserved 
 
  
Code (Note: Use intermediate codes when appropriate, e.g., 45, 68, 
72.)  
100 Superior functioning in a wide range of activities. 
 | 91 90 Good functioning in all areas, occupationally and socially effective 
 | 81 80No more than a slight impairment in social, occupational, or school 
functioning (e.g., infrequent interpersonal conflict, temporarily falling behind in 
schoolwork). 
 | 71 70Some difficulty in social, occupational, or school functioning, but generally 
functioning well, has some meaningful interpersonal relationships. 
 | 61 60 Moderate difficulties in social, occupational, or school functioning (e.g., few 
friends, conflicts with peers or co-workers). 
 | 51 50Serious impairments in social, occupational, or school functioning (e.g., no 
friends, unable to keep a job). 
 | 41 40Major impairments in several areas, such as work or school, family relations 
friends, neglects family, and is unable to work; child frequently beats up younger 
children, is defiant at home, and is failing at school). 
 | 31 30 Inability to function in almost all areas (e.g., stays in bed all day; no job, 
home, or friends). | 21 20 Occasionally fails to maintain minimal personal hygiene; 
unable to function independently. 
 | 11 10Persistent inabilities to maintain minimal personal hygiene. Unable to function 
without harming self or others or without considerable external support (e.g., nursing 
care and supervision). 
 | 1 0 Inadequate information. 
 
 
  
SOCIODEMOGRAPHIC PROFILE 
 PARTICIPANT NO - 
 OP NO - 
 IP NO - 
 NAME - 
 AGE - 
 SEX - 
 EDUCATION - 
 OCCUPATION - 
 DURATION OF UMEMPLOYED IF - 
 MARIETAL STATUS - 
 ECONOMIC STATUS - 
 ADDRESS - 
 RELIGION - 
 NATIONALITY - 
 INFORMANT - 
 FAMILY - 
 INCOME - 
 INCOME - - 
 HOUSING - 
 DOMICILE - 
 PROPERTY LOSS - 
 DEBT` - 
 
 
 
 FAMILY DETAILS 
 SPOUSE NAME 
 SPOUCE OCCUPATION 
 SPOUSE EDUCATION STATUS 
 NO OF CHILDRENS 
 EDUCATION STATUS OF CHILDRENS 
 MODE OF EDUCATION PREVAILING 
 
ILLNESS PARAMETERS - GENERAL 
 AGE OF ONSET 
 TOTAL DURATION 
 NO.OF.EPISODES 
 NO.OF.HOSPITALISATIONS 
 FAMILY HISTORY 
 MEDICAL COMORBIDITY 
 H/O SUICIDAL WISHES/ ATTEMPTS 
 H/O ECT 
 H/O OCCUPATIONAL IMPAIRMENT 
 H/O DECREASE IN MONETORY PRODUCTIVITY 
 NO OF DAYS ABSENCE FROM WORK 
 SUBSTANCE USE 
 IDENTIFIABLE STRESSOR PRECEDING ILLNESS 
 LEGAL ISSUES 
 
 
ILLNESS PARAMETERS RELATED TO DEPRESSION 
 ONSET 
 DURATION 
 NO OF EPISODES 
 POLARITY 
 NO OF HOSPITALISATION 
 DEPRESSED COGNITION 
 PREDOMINANT DEPRESSIVE SYMPTOMS 
 PSYCHOMOTOR ACTIVITY 
 SLEEP 
 APETITE 
 SEXUAL FUNCTION 
 ANHEDONIA 
 SUICIDAL WISH/ ATTEMPT 
 LOSS OF JOB 
 RELATION SHIP ISSUES 
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1 32 1 6 3 3 4 1 1 1 1 1 Y Y 2 32 1 N 1 0 Y 2 Y 3 0 0 N 2 1 Y 1 64 A 16 20 43
2 27 2 7 9 3 4 3 2 1 2 1 N N 0 27 1 N 0 0 N 0 Y 3 0 1 N 0 0 Y 1 63 A 9 20 42
3 36 2 4 4 1 1 1 1 1 1 2 Y Y 2 32 2 Y 1 2 Y 1 Y 3 1 1 N 2 0 Y 2 61 A 12 19 42
4 45 1 2 2 1 1 1 1 1 2 2 Y Y 2 40 2 Y 0 2 Y 3 Y 1,2 0 0 N 2 1,2 Y 3 66 A 19 12 52
5 65 1 2 2 1 2 2 1 2 2 2 Y Y 3 42 3 Y 2 3 Y 1 Y 1,2,4 0 0 Y 2 1,2 Y 2 42 NA 23 12 53
6 65 1 2 2 1 2 2 1 1 2 2 Y Y 3 35 3 Y 2 3 Y 1 Y 1,2,4 0 0 Y 2 1,2 Y 2 41 NA 24 13 53
7 38 0 2 3 2 1 3 3 3 1 2 Y N 0 32 2 Y 0 2 Y 3 Y 1,2 1 2 N 2 0 Y 2 64 A 9 22 42
8 30 2 7 9 3 4 3 2 1 2 1 N N 0 30 1 N 0 0 N 0 Y 3 0 1 N 0 0 Y 1 68 A 9 22 43
9 40 2 3 3 2 2 2 3 2 1 2 Y Y 2 34 2 Y 1 1 Y 2 Y 1,2,3 1 1 N 2 1 Y 1 66 A 11 22 43
10 40 2 2 2 1 2 2 3 1 1 2 N Y 3 32 3 Y 3 2 Y 4 Y 1,2,3 2 2 Y 2 1 Y 3 41 NA 19 21 41
11 36 2 2 2 1 2 3 3 3 2 2 Y Y 3 34 2 Y 1 1 Y 2 Y 3 1 0 Y 2 0 Y 3 69 A 9 23 43
12 38 2 2 3 2 1 3 3 3 1 2 Y N 0 36 2 Y 0 2 Y 3 Y 1,2 1 2 N 2 0 Y 2 71 A 10 24 44
13 54 2 2 2 1 2 2 1 3 1 2 Y Y 2 45 2 Y 1 2 Y 2 Y 4 1 1 N 2 1 Y 1 34 NA 19 12 53
14 42 2 3 3 2 2 3 2 1 1 1 N N 0 40 2 Y 0 1 N 0 Y 1,2 0 0 N 2 1 N 1 38 NA 21 18 44
15 34 1 6 3 3 4 1 1 1 1 1 Y Y 2 34 1 N 0 0 Y 2 Y 3 0 0 N 2 1 Y 1 72 A 9 22 43
16 22 2 4 4 2 2 2 2 1 1 N N 0 22 1 N 0 0 Y 2 Y 3 0 0 N 1 0 Y 3 73 A 8 14 44
17 36 2 4 4 1 1 1 1 1 1 2 Y Y 2 35 2 Y 1 2 Y 1 Y 3 1 1 N 2 0 Y 2 42 NA 18 12 52
18 26 1 3 3 2 1 2 2 1 1 2 Y Y 2 26 1 N 0 0 N 0 N 0 0 N 2 1,2 N 3 43 NA 8 23 63
19 40 1 3 3 2 2 2 2 1 2 2 Y Y 2 36 2 Y 1 1 Y 2 Y 1 0 0 N 2 1,2,3 Y 3 72 A 22 21 43
20 30 2 2 2 2 1 1 2 3 1 2 N N 0 23 3 Y 0 1 Y 1 Y 3 2 2 N 2 1 Y 3 32 NA 7 12 63
21 49 1 2 2 1 2 2 1 1 2 2 Y Y 3 40 3 Y 2 3 Y 1 Y 1,2,4 0 0 Y 2 1,2 Y 2 68 A 22 18 42
22 24 2 4 4 2 2 2 2 1 1 N N 0 24 1 N 0 0 Y 2 Y 3 0 0 N 1 0 Y 3 72 A 7 23 46
23 45 1 2 2 1 2 2 1 1 1 1 N N 0 41 2 N 0 0 Y 1,2 N 1 1 Y 2 1 Y 3 68 A 19 22 53
24 50 1 3 3 2 2 2 1 1 1 1 N N 0 43 3 Y 1 1 Y 2 Y 1,2 1 2 Y 2 1,2 N 3 44 NA 24 14 52
25 30 2 3 4 2 2 2 2 1 1 2 N Y 2 23 2 Y 1 1 Y 2 Y 1,2 1 0 Y 2 1,2 Y 3 68 A 8 21 44
26 40 1 2 2 1 2 2 1 1 1 1 N N 0 38 2 N 0 0 Y 1,2 N 1 1 Y 2 1 Y 3 69 A 19 18 52
27 40 1 3 3 2 2 2 1 1 1 1 N N 0 32 3 Y 1 1 Y 2 Y 1,2 1 2 Y 2 1,2 N 3 46 NA 19 17 54
28 30 2 3 4 2 2 2 2 1 1 2 N Y 2 24 2 Y 1 1 Y 2 Y 1,2 1 0 Y 2 1,2 Y 3 65 A 7 23 41
29 50 2 2 2 2 1 1 2 3 1 2 N N 0 32 3 Y 0 1 Y 1 Y 3 2 2 N 2 1 Y 3 39 NA 21 21 53
30 35 1 2 2 1 2 2 1 2 2 2 Y Y 3 25 3 Y 2 3 Y 1 Y 1,2,4 0 0 Y 2 1,2 Y 2 64 A 9 22 42
31 29 1 4 4 4 3 3 1 1 1 1 n y 2 29 1 n 0 0 y 2 y 3 0 0 n 3 2 y 3 71 A 8 22 43
32 48 2 3 7 6 2 3 3 1 1 1 y y 2 48 1 y 0 2 y 2 y 1,2 1 2 n 3 0 y 2 66 A 22 21 41
33 38 1 4 5 4 2 2 1 2 2 2 y y 3 33 3 y 2 1 y 4 y 4 1 2 y 2 1,2 y 2 64 A 8 13 53
34 44 1 4 8 6 1 2 1 2 2 3 y y 1 40 3 y 1 2 n 0 n 0 1 2 y 3 2,3 y 3 63 A 8 15 47
35 22 1 5 7 6 2 2 2 1 2 1 n n 0 22 1 n 0 0 y 4 n 0 0 0 n 2 3 y 3 71 A 9 22 48
36 39 1 5 6 6 2 1 1 1 1 1 y y 2 26 3 y 1 2 y 0 y 4 2 2 y 3 2,3,4 y 2 64 A 12 16 52
37 38 1 4 6 5 2 2 1 1 1 2 y y 2 36 2 n 0 0 n 0 n 0 1 1 n 2 1,2 y 1 73 A 9 17 51
38 36 1 7 8 3 3 3 1 3 2 2 y y 3 24 3 y 3 2 y 2 y 3 1 1 y 3 1,2 y 3 70 A 17 17 53
39 50 1 1 1 1 1 3 1 1 1 1 y y 2 26 3 y 2 4 y 4 y 1,2,4 1 1 y 3 1,2 y 1 40 NA 21 21 41
40 44 1 2 2 2 2 2 2 1 2 2 y y 3 30 1 y 2 3 y 3 y 1,2 1 1 y 3 1,2,3 y 1 68 A 19 16 52
41 40 2 2 2 2 1 1 2 1 1 1 y y 2 35 2 y 1 2 y 3 y 2,3 1 1 n 2 1 y 1 70 A 18 17 53
42 60 2 1 1 1 1 1 1 1 1 1 y y 2 30 3 y 3 4 y 2 y 1,2,4 1 1 y 3 1 y 3 34 NA 22 18 53
43 45 2 3 5 2 2 2 2 1 2 2 y y 2 40 3 y 0 1 n 0 y 3 0 0 n 2 0 y 1 43 NA 21 18 54
44 44 1 1 1 1 1 1 2 1 2 1 y y 2 43 2 y 2 3 y 2 y 2 0 0 n 3 2,3 y 3 43 NA 22 17 42
45 26 2 6 8 3 3 3 2 1 1 2 n n 0 24 2 n 0 0 y 4 y 3 0 0 n 2 0 y 1 61 A 9 12 52
46 21 2 5 1 1 4 2 2 1 1 1 n n 0 21 1 n 0 0 n 0 y 3 0 0 n 1 0 y 3 69 A 9 13 52
47 35 2 3 4 2 2 2 2 2 2 2 y y 1 33 2 y 1 1 y 2 y 1,3 1 1 n 3 0 y 2 40 NA 11 13 61
48 61 1 1 1 1 1 1 1 1 1 1 y n 0 61 1 y 1 3 n 0 y 2,4 0 0 n 2 1 n 1 36 NA 23 18 52
49 35 2 4 4 2 2 1 2 1 1 2 n n 0 33 2 n 0 0 n 0 y 3 0 0 n 2 0 y 2 71 A 8 17 63
50 50 1 2 2 2 2 2 1 1 2 2 n n 0 50 2 y 2 3 y 2 y 2 0 0 n 2 2,3 y 2 36 NA 23 14 47
51 24 2 4 4 4 3 2 2 1 2 2 n n 0 24 1 n 0 0 n 0 n 0 0 0 n 3 0 y 3 36 NA 9 12 62
52 47 2 2 2 2 2 2 2 1 2 2 y y 2 24 3 y 2 3 y 3 y 3 0 0 n 1 0 y 3 44 NA 8 13 63
53 36 2 2 2 2 2 2 2 1 1 2 n n 0 19 3 y 1 2 n 0 y 3 0 0 n 3 0 y 1 36 NA 9 12 63
54 50 2 2 2 2 2 3 1 1 1 1 y y 2 26 3 y 2 4 y 1,2 y 1,2,3 1 1 y 3 0 y 1 41 NA 12 14 61
55 45 2 4 4 3 3 2 2 1 1 2 y y 2 40 2 y 1 2 y 3 y 3 0 0 n 3 0 y 1 40 NA 10 13 63
56 50 2 2 3 2 2 2 1 1 2 1 y y 1 46 3 y 2 3 y 3 y 2 0 0 n 2 0 y 1 36 NA 18 18 52
57 38 2 4 7 4 3 3 3 1 2 2 y y 3 26 3 n 0 0 n 0 n 0 0 0 n 2 0 y 1 73 A 8 21 42
58 30 2 3 4 4 2 2 1 1 2 2 y n 0 19 2 n 0 0 n 0 n 0 0 0 n 3 0 y 1 68 A 9 22 43
59 41 2 2 2 2 2 1 1 1 1 1 n n 0 34 3 y 2 4 y 3 n 0 0 0 n 2 1 y 2 73 A 8 22 44
60 53 2 2 2 2 2 1 1 1 2 2 y y 2 30 3 y 2 3 y 3 y 1,2 0 0 n 2 0 n 2 28 NA 19 17 52
61 23 2 4 4 1 2 2 2 1 2 2 n n 0 23 1 n 0 0 n 0 n 0 0 0 n 2 0 y 3 66 A 13 21 43
62 40 2 4 4 2 2 3 2 1 2 2 y y 2 26 2 y 2 3 y 3 y 3 1 1 y 3 0 y 3 48 NA 18 22 42
63 36 2 4 4 2 3 2 1 1 2 2 Y N 0 36 2 N 0 0 Y 2 Y 3 1 0 N 2 0 Y 2 66 A 13 21 44
64 40 2 3 3 4 3 2 1 1 1 1 N N 0 32 3 Y 1 1 Y 1 N 0 1 1 Y 3 0 Y 2 73 A 14 22 43
65 26 2 6 8 3 3 2 2 1 2 1 N N 0 26 1 N 0 0 N 0 Y 3 0 0 N 2 0 Y 3 69 A 13 21 44
66 46 2 4 7 5 3 2 1 1 1 1 Y Y 2 23 3 Y 2 0 N 0 Y 2,3 0 0 N 3 0 N 1 46 NA 19 20 42
67 26 2 2 3 2 2 2 2 1 2 2 N N 0 26 1 N 0 0 Y 4 N 0 0 0 N 2 0 N 1 64 A 9 19 43
68 40 2 4 4 3 2 2 1 1 1 1 N N 0 32 2 N 0 0 Y 3 N 0 0 0 N 2 0 N 2 39 NA 18 21 44
69 35 2 4 4 3 2 2 1 1 1 1 N N 0 32 2 N 0 0 Y 3 N 0 0 0 N 2 0 N 2 66 A 9 21 46
70 36 2 4 4 3 2 2 1 1 1 1 N N 0 32 2 N 0 0 Y 3 N 0 0 0 N 2 0 N 2 43 NA 18 14 52
71 52 2 1 2 1 2 2 1 1 1 1 N N 0 32 2 N 0 0 Y 3 N 0 0 0 N 2 0 N 2 39 NA 24 16 45
72 58 2 1 2 1 2 2 1 1 1 1 Y Y 2 23 3 Y 1 1 Y 2 Y 1,2 1 1 Y 2 0 Y 2 40 NA 25 15 43
73 49 2 1 2 1 2 2 1 1 1 1 Y Y 2 23 3 Y 1 1 Y 2 Y 1,2 1 1 Y 2 0 Y 2 36 NA 26 16 49
74 30 2 6 8 3 3 2 1 1 1 1 N N 0 26 3 Y 0 0 N 0 Y 3 0 0 N 2 0 Y 2 71 A 9 21 53
75 52 2 1 3 1 2 2 1 1 1 1 Y N 0 23 3 Y 1 1 Y 2 Y 1,2 1 1 Y 2 0 Y 2 39 NA 24 13 53
76 63 2 1 3 1 2 2 1 1 1 1 Y N 0 23 3 Y 1 1 Y 2 Y 1,2 1 1 Y 2 0 Y 2 43 NA 19 13 53
77 55 2 1 3 1 2 2 1 1 1 1 Y N 0 23 3 Y 1 1 Y 2 Y 1,2 1 1 Y 2 0 Y 2 44 NA 18 14 52
78 46 2 4 7 5 3 2 1 1 1 1 Y Y 2 23 3 Y 2 0 N 0 Y 2,3 0 0 N 3 0 N 1 39 NA 17 15 54
79 35 2 6 8 3 3 2 1 1 1 1 N N 0 26 3 Y 0 0 N 0 Y 3 0 0 N 2 0 Y 2 46 NA 21 17 56
80 38 2 4 4 3 2 2 1 1 1 1 N N 0 32 2 N 0 0 Y 3 N 0 0 0 N 2 0 N 2 36 NA 23 18 54
81 40 2 4 4 3 2 2 1 1 1 1 N N 0 32 2 N 0 0 Y 3 N 0 0 0 N 2 0 N 2 39 NA 21 15 58
82 56 2 1 2 1 2 2 1 1 1 1 Y Y 2 23 3 Y 1 1 Y 2 Y 1,2 1 1 Y 2 0 Y 2 34 NA 24 11 54
83 48 2 1 3 1 2 2 1 1 1 1 Y N 0 23 3 Y 1 1 Y 2 Y 1,2 1 1 Y 2 0 Y 2 36 NA 22 18 53
84 28 2 2 3 2 2 2 2 1 2 2 N N 0 26 1 N 0 0 Y 4 N 0 0 0 N 2 0 N 1 67 A 9 22 43
85 29 1 2 3 2 2 2 2 2 2 2 N N 0 26 1 N 0 0 Y 4 N 0 0 0 N 2 0 N 1 64 A 8 22 44
86 40 1 2 2 2 2 2 2 3 2 2 y y 3 30 1 y 2 3 y 3 y 1,2 1 1 y 3 1,2,3 y 1 64 A 9 17 51
87 42 1 2 2 2 2 2 2 3 2 2 y y 3 30 1 y 2 3 y 3 y 1,2 1 1 y 3 1,2,3 y 1 66 A 9 17 53
88 32 1 4 6 5 2 2 1 1 1 2 y y 2 36 2 n 0 0 n 0 n 0 1 1 n 2 1,2 y 1 71 A 13 13 52
89 40 1 5 6 6 2 1 1 1 1 1 y y 2 26 3 y 1 2 y 0 y 4 2 2 y 3 2,3,4 y 2 72 A 9 14 53
90 52 1 2 2 1 2 2 1 2 2 2 Y Y 3 45 3 Y 2 3 Y 1 Y 1,2,4 0 0 Y 2 1,2 Y 2 63 A 8 12 54
91 36 1 2 2 2 2 2 2 1 2 2 y y 3 30 1 y 2 3 y 3 y 1,2 1 1 y 3 1,2,3 y 1 66 A 6 12 53
92 40 1 5 6 6 2 1 1 1 1 1 y y 2 26 3 y 1 2 y 0 y 4 2 2 y 3 2,3,4 y 2 72 A 9 14 53
93 40 1 5 6 6 2 1 1 1 1 1 y y 2 26 3 y 1 2 y 0 y 4 2 2 y 3 2,3,4 y 2 72 A 9 14 53
94 32 1 4 6 5 2 2 1 1 1 2 y y 2 36 2 n 0 0 n 0 n 0 1 1 n 2 1,2 y 1 71 A 13 13 52
95 36 1 2 2 2 2 2 2 1 2 2 y y 3 30 1 y 2 3 y 3 y 1,2 1 1 y 3 1,2,3 y 1 66 A 6 12 53
96 35 1 2 2 2 2 2 2 3 2 2 y y 3 30 1 y 2 3 y 3 y 1,2 1 1 y 3 1,2,3 y 1 66 A 9 17 53
97 38 1 2 2 2 2 2 2 3 2 2 y y 3 30 1 y 2 3 y 3 y 1,2 1 1 y 3 1,2,3 y 1 66 A 9 17 53
98 40 1 5 6 6 2 1 1 1 1 1 y y 2 26 3 y 1 2 y 0 y 4 2 2 y 3 2,3,4 y 2 72 A 9 14 53
99 36 1 4 6 5 2 2 1 1 1 2 y y 2 36 2 n 0 0 n 0 n 0 1 1 n 2 1,2 y 1 71 A 13 13 52
100 34 1 5 6 6 2 1 1 1 1 1 y y 2 26 3 y 1 2 y 0 y 4 2 2 y 3 2,3,4 y 2 72 A 9 11 53
